b'<?xml version="1.0" encoding="utf-8"?>\n<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">\n<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">\n    \n    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />\n        <!-- AppResources meta begin -->\n        <script type="text/javascript">var ncbi_startTime = new Date();</script>\n        <!-- AppResources meta end -->\n        \n        <!-- TemplateResources meta begin -->\n        <meta name="paf_template" content="" />\n\n        <!-- TemplateResources meta end -->\n        \n        <!-- Logger begin -->\n        <meta name="ncbi_db" content="pmc" /><meta name="ncbi_pdid" content="article" /><meta name="ncbi_acc" content="" /><meta name="ncbi_domain" content="phenaturepg" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/articles/PMC2792222/" /><meta name="ncbi_app" content="pmc" />\n        <!-- Logger end -->\n        \n        <title>Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV</title>\n        \n        <!-- AppResources external_resources begin -->\n        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>\n\n        <!-- AppResources external_resources end -->\n        \n        <!-- Page meta begin -->\n        <meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792222/" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="citation_journal_title" content="BMC Immunology" /><meta name="citation_title" content="Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV" /><meta name="citation_authors" content="Yanbo Lv, Zhihua Ruan, Li Wang, Bing Ni, Yuzhang Wu" /><meta name="citation_date" content="2009" /><meta name="citation_volume" content="10" /><meta name="citation_doi" content="10.1186/1471-2172-10-61" /><meta name="citation_abstract_html_url" content="/pmc/articles/PMC2792222/?report=abstract" /><meta name="citation_pmid" content="19958537" /><meta name="DC.Title" content="Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="Nature Publishing Group" /><meta name="DC.Contributor" content="Yanbo Lv" /><meta name="DC.Contributor" content="Zhihua Ruan" /><meta name="DC.Contributor" content="Li Wang" /><meta name="DC.Contributor" content="Bing Ni" /><meta name="DC.Contributor" content="Yuzhang Wu" /><meta name="DC.Date" content="2009" /><meta name="DC.Identifier" content="10.1186/1471-2172-10-61" /><meta name="DC.Language" content="en" /><meta property="og:title" content="Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV" /><meta property="og:type" content="article" /><meta property="og:description" content="The spike (S) protein is a major structural glycoprotein of coronavirus (CoV), the causal agent of severe acute respiratory syndrome (SARS). The S protein is a potent target for SARS-specific cell-mediated immune responses. However, the mechanism CoV ..." /><meta property="og:url" content="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2792222/" /><meta property="og:site_name" content="PubMed Central (PMC)" /><meta property="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/pmc-logo-share.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbi" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/3.14.1/pmc_extras_prnt.min.css" type="text/css" media="print" /><script type="text/javascript" src="/corehtml/pmc/js/common.min.js">//</script><script type="text/javascript" src="/corehtml/pmc/js/NcbiTagServer.min.js">//</script><meta name="citationexporter" content="backend:\'https://api.ncbi.nlm.nih.gov/lit/ctxp/v1/pmc/\'" /><script type="text/javascript" src="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/jquery.citationexporter.min.js">//</script><link rel="stylesheet" href="https://www.ncbi.nlm.nih.gov/corehtml/pmc/ctxp/citationexporter.css" type="text/css" /><script type="text/javascript">window.name="mainwindow";</script><style type="text/css">.pmc-wm {background:transparent repeat-y top left;background-image:url(/corehtml/pmc/pmcgifs/wm-phenaturepg.gif);background-size: auto, contain}</style><style type="text/css">.print-view{display:block}</style><style type="text/css">\n        div.pmc_para_cit li.highlight,\n        div.pmc_para_cit li.highlight .one_line_source\n        { background: #E0E0E0; }\n        a.bibr.highlight { background: #E0E0E0; } \n      </style><meta name="cited_in_systematic_reviews" content="" /><link rel="alternate" type="application/epub+zip" href="/pmc/articles/PMC2792222/epub/" /><link rel="alternate" type="application/pdf" href="/pmc/articles/PMC2792222/pdf/12865_2009_Article_281.pdf" />\n\n        <!-- Page meta end -->\n    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="8A1B7671E9A3857100000000066D066C.m_8" />\n<meta name=\'referrer\' content=\'origin-when-cross-origin\'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4048120/3846471/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/3881636/3579733/4062871/12930/3964959/3855473/4047625/3854974/3854955/4076335/4128070/9685/3549676/3609192/3609193/3609213/3395586/4143404.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/css/3411343/3882866/4157116.css" media="print" /></head>\n    <body class="article">\n        <div class="grid">\n            <div class="col twelve_col nomargin shadow">\n                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->\n                <div class="sysmessages">\n                    <noscript>\n\t<p class="nojs">\n\t<strong>Warning:</strong>\n\tThe NCBI web site requires JavaScript to function. \n\t<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>\n\t</p>\n\t</noscript>\n                </div>\n                <!--/.sysmessage-->\n                <div class="wrap">\n                    <div class="page">\n                        <div class="top">\n                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main\n                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to\n                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>\n                            <div class="header">\n    <div class="res_logo">\n  <h1 class="img_logo"><a href="/pmc/" class="pmc_logo offscreen">PMC</a></h1>\n  <div class="NLMLogo">\n    <a href="https://www.nlm.nih.gov/" title="US National Library of Medicine">US National Library of Medicine</a>\n    <br />\n    <a href="https://www.nih.gov/" title="National Institutes of Health">National Institutes of Health</a>\n  </div>\n</div>\n    <div class="search"><form method="get" action="/pmc/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="pmc" selected="selected" class="last" data-ac_dict="pmc-search-autocomplete">PMC</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc" data-ac_dict="pmc-search-autocomplete">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search PMC. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:\'pmc-search-autocomplete\',disableUrl:\'NcbiSearchBarAutoComplCtrl\'" autocomplete="off" data-sbconfig="ds:\'no\',pjs:\'no\',afs:\'yes\'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>\n                        <a href="/pmc/advanced/">Advanced</a>\n                    </li><li>\n                        <a href="/pmc/journals/">Journal list</a>\n                    </li><li class="help">\n                        <a target="_blank" href="/books/NBK3825/">Help</a>\n                    </li></ul></div>\n</div>\n\n                            \n                            \n                        <!--<component id="Page" label="headcontent"/>-->\n                            \n                        </div>\n                        <div class="content">\n                            <!-- site messages -->\n                            <div class="container">\n    <div id="maincontent" class="content eight_col col">\n        <div class="navlink-box">\n            <ul class="page-breadcrumbs inline_list small"><li class="journal-list"><a href="/pmc/journals/" class="navlink">Journal List</a></li><li class="article-entrez-filter"><a href="/pmc/?term=Nature%20Public%20Health%20Emergency%20Collection[filter]" class="navlink">Nature Public Health Emergency Collection</a></li><li class="accid">PMC2792222</li></ul>\n        </div>\n\n        <!-- Journal banner -->\n        <div class="pmc-page-banner whole_rhythm"><div class="banner-generic-logo-background inline_block"><div class="banner-journal-publisher-over-image"><div class="banner-journal-name bl-jtitle-phenaturepg">BMC Immunology</div><div class="banner-publisher-name">Nature Publishing Group</div></div></div></div>\n        \n        <!--component id=\'MainPortlet\' label=\'search-reference\'/-->\n        \n        <!-- Book content -->\n        <div class="">\n            \n        \n            \n            <div class="hide-overflow article lit-style content pmc-wm slang-all page-box"><!--main-content--><div class="jig-ncbiinpagenav" data-jigconfig="smoothScroll: false, allHeadingLevels: [\'h2\'], headingExclude: \':hidden\'"><div class="fm-sec half_rhythm no_top_margin"><div class="fm-citation half_rhythm no_top_margin clearfix"><div class="inline_block eight_col va_top"><div><div><span class="cit"><span id="pmcmata">BMC Immunol</span>. 2009; 10: 61. </span></div><div><span class="fm-vol-iss-date">Published online 2009 Dec 3. </span>  <span class="doi">doi:\xc2\xa0<a href="//dx.doi.org/10.1186%2F1471-2172-10-61" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CFront%20Matter&amp;TO=Content%20Provider%7CCrosslink%7CDOI">10.1186/1471-2172-10-61</a></span></div></div></div><div class="inline_block four_col va_top show-overflow align_right"><div class="fm-citation-ids"><div class="fm-citation-pmcid"><span class="fm-citation-ids-label">PMCID: </span><span>PMC2792222</span></div><div class="fm-citation-pmid">PMID: <a href="/pubmed/19958537">19958537</a></div></div></div></div><h1 class="content-title">Identification of a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV</h1><div class="half_rhythm"><div class="contrib-group fm-author"><a href="/pubmed/?term=Lv%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19958537" class="affpopup" co-rid="_co_idm140138202801312" co-class="co-affbox">Yanbo Lv</a>,<sup></sup> <a href="/pubmed/?term=Ruan%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19958537" class="affpopup" co-rid="_co_idm140138203003856" co-class="co-affbox">Zhihua Ruan</a>,<sup></sup> <a href="/pubmed/?term=Wang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19958537" class="affpopup" co-rid="_co_idm140138199804096" co-class="co-affbox">Li Wang</a>,<sup></sup> <a href="/pubmed/?term=Ni%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19958537" class="affpopup" co-rid="_co_idm140138199802080" co-class="co-affbox">Bing Ni</a>,<sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup> and  <a href="/pubmed/?term=Wu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19958537" class="affpopup" co-rid="_co_idm140138195004208" co-class="co-affbox">Yuzhang Wu</a><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup><sup></sup></div><div style="display:none" class="contrib-group aff-tip"><div id="_co_idm140138202801312"><h3 class="no_margin">Yanbo Lv</h3><p>Institute of Immunology, PLA, Third Military Medical University, 30 Gaotanyan Street, Chongqing, 400038 PR China </p><div>Find articles by <a href="/pubmed/?term=Lv%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19958537">Yanbo Lv</a></div></div><div id="_co_idm140138203003856"><h3 class="no_margin">Zhihua Ruan</h3><p>Institute of Immunology, PLA, Third Military Medical University, 30 Gaotanyan Street, Chongqing, 400038 PR China </p><div>Find articles by <a href="/pubmed/?term=Ruan%20Z%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19958537">Zhihua Ruan</a></div></div><div id="_co_idm140138199804096"><h3 class="no_margin">Li Wang</h3><p>Institute of Immunology, PLA, Third Military Medical University, 30 Gaotanyan Street, Chongqing, 400038 PR China </p><div>Find articles by <a href="/pubmed/?term=Wang%20L%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19958537">Li Wang</a></div></div><div id="_co_idm140138199802080"><h3 class="no_margin">Bing Ni</h3><p>Institute of Immunology, PLA, Third Military Medical University, 30 Gaotanyan Street, Chongqing, 400038 PR China </p><div>Find articles by <a href="/pubmed/?term=Ni%20B%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19958537">Bing Ni</a></div></div><div id="_co_idm140138195004208"><h3 class="no_margin">Yuzhang Wu</h3><p>Institute of Immunology, PLA, Third Military Medical University, 30 Gaotanyan Street, Chongqing, 400038 PR China </p><div>Find articles by <a href="/pubmed/?term=Wu%20Y%5BAuthor%5D&amp;cauthor=true&amp;cauthor_uid=19958537">Yuzhang Wu</a></div></div></div></div><div class="fm-panel half_rhythm"><div class="togglers"><a href="#" class="pmctoggle" rid="idm140138195365440_ai">Author information</a> <a href="#" class="pmctoggle" rid="idm140138195365440_an">Article notes</a> <a href="#" class="pmctoggle" rid="idm140138195365440_cpl">Copyright and License information</a> <a href="/pmc/about/disclaimer/">Disclaimer</a></div><div class="fm-authors-info fm-panel hide half_rhythm" id="idm140138195365440_ai" style="display:none"><div class="fm-affl" lang="en" id="Aff1">Institute of Immunology, PLA, Third Military Medical University, 30 Gaotanyan Street, Chongqing, 400038 PR China </div><div><span class="fm-affl">Yanbo Lv, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.moc.anis@lyob" class="oemail">nc.moc.anis@lyob</a></span>.</div><div><a href="#idm140138195365440aff-info">Contributor Information</a>.</div><div><sup><img src="/corehtml/pmc/pmcgifs/corrauth.gif" alt="corresponding author" /></sup>Corresponding author.</div></div><div class="fm-article-notes fm-panel hide half_rhythm" id="idm140138195365440_an" style="display:none"><div class="fm-pubdate half_rhythm">Received 2009 Jul 23; Accepted 2009 Dec 3.</div></div><div class="permissions fm-panel half_rhythm hide" id="idm140138195365440_cpl" style="display:none"><div class="fm-copyright half_rhythm"><a href="/pmc/about/copyright/">Copyright</a> &#x000a9; Lv et al; licensee BioMed Central Ltd. 2009</div><div class="license half_rhythm">This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.</div></div></div><div id="pmclinksbox" class="links-box whole_rhythm"><div class="fm-panel"><div>This article has been <a href="/pmc/articles/PMC2792222/citedby/">cited by</a> other articles in PMC.</div></div></div></div><div class="sec"></div><div id="Abs1" lang="en" class="tsec sec"><h2 class="head no_bottom_margin" id="Abs1title">Abstract</h2><!--article-meta--><div><div id="__sec1" class="sec sec-first"><h3 id="__sec1title">Background</h3><p id="__p1" class="p p-first-last">The spike (S) protein is a major structural glycoprotein of coronavirus (CoV), the causal agent of severe acute respiratory syndrome (SARS). The S protein is a potent target for SARS-specific cell-mediated immune responses. However, the mechanism CoV pathogenesis in SARS and the role of special CTLs in virus clearance are still largely uncharacterized. Here, we describe a study that leads to the identification of a novel HLA-A*0201-restricted epitope from conserved regions of S protein.</p></div><div id="__sec2" class="sec"><h3 id="__sec2title">Results</h3><p id="__p2" class="p p-first-last">First, different SARS-CoV sequences were analyzed to predict eight candidate peptides from conserved regions of the S protein based upon HLA-A*0201 binding and proteosomal cleavage. Four of eight candidate peptides were tested by HLA-A*0201 binding assays. Among the four candidate peptides, Sp8 (S<sub>958-966</sub>, VLNDILSRL) induced specific CTLs both <em>ex vivo</em> in PBLs of healthy HLA-A2<sup>+</sup> donors and in HLA-A2.1/K<sup>b</sup> transgenic mice immunized with a plasmid encoding full-length S protein. The immunized mice released IFN-&#x003b3; and lysed target cells upon stimulation with Sp8 peptide-pulsed autologous dendritic cells in comparison to other candidates.</p></div><div id="__sec3" class="sec"><h3 id="__sec3title">Conclusion</h3><p id="__p3" class="p p-first-last">These results suggest that Sp8 is a naturally processed epitope. We propose that Sp8 epitope should help in the characterization of mechanisms of virus control and immunopathology in SARS-CoV infection.</p></div><div id="__sec4" class="sec sec-last"><h3 id="__sec4title">Electronic supplementary material</h3><p id="__p4" class="p p-first-last">The online version of this article (doi:10.1186/1471-2172-10-61) contains supplementary material, which is available to authorized users.</p></div></div><div class="sec"><strong class="kwd-title">Keywords: </strong><span class="kwd-text">Severe Acute Respiratory Syndrome, Severe Acute Respiratory Syndrome, Transporter Associate With Antigen Processing, Fluorescence Index, Candidate Peptide</span></div></div><div id="Sec1" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec1title">Background</h2><p id="__p5" class="p p-first">Severe acute respiratory syndrome (SARS), a newly emerging infectious disease, is caused by a SARS-associated coronavirus (SARS-CoV) [<a href="#CR1" rid="CR1" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978897">1</a>&#x02013;<a href="#CR3" rid="CR3" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471680">3</a>], which may originate from some wild animals [<a href="#CR4" rid="CR4" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978934">4</a>]. After its first occurrence, SARS rapidly spread around the world along international air-travel routes, reaching all five continents and resulting in several hundreds of deaths [<a href="#CR5" rid="CR5" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978945">5</a>]. The most recent epidemic of SARS occurred in Beijing and Anhui, China in April 2004 and originated from laboratory contamination (WHO update 7; see Further Information). Although the outbreaks seem to be over, SARS remains a safety concern because of the possible reintroduction of a SARS-like coronavirus (SL-CoV) into humans and the risk of an escape of SARS-CoV from laboratories [<a href="#CR6" rid="CR6" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978944">6</a>&#x02013;<a href="#CR8" rid="CR8" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471684">8</a>]. More importantly, a new recombinant virus derived from human [<a href="#CR9" rid="CR9" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_845199397">9</a>], swine and/or avian influenza virus, might re-emerge as a new SARS-CoV type, much like the recent emergence of a novel swine-origin influenza A (H1N1) in humans. Thus, it is essential to develop various and distinct strategies to combat this highly contagious disease.</p><p id="__p6">The published literature reports that high titres of neutralizing antibodies and SARS-CoV-specific cytotoxic T lymphocyte (CTL) responses were detected in patients who had recovered from SARS [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978911">10</a>, <a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978905">11</a>], and the levels of those responses correlated well with disease outcome [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978948">12</a>]. Hence, both humoral and cellular immune responses appear to be crucial for the clearance of SARS-CoV infection. Immune responses can be raised directly against several of the SARS-CoV proteins [<a href="#CR13" rid="CR13" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471681">13</a>&#x02013;<a href="#CR15" rid="CR15" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978952">15</a>]. Targeting the spike (S) structural glycoprotein [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978925">12</a>, <a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978929">16</a>&#x02013;<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471688">18</a>] in particular induces a robust immune response, suggesting it plays an important role in the systemic clearance of SARS-CoV [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978930">10</a>]. The viral surface S protein is involved in host cell receptor recognition, virus attachment and entry [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978936">19</a>]; adaptive evolution of S protein, thus, contributes to SARS-CoV overcoming the species barrier [<a href="#CR20" rid="CR20" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978932">20</a>]. Hence, many vaccines and therapeutics against SARS-CoV target the S protein [<a href="#CR19" rid="CR19" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978937">19</a>]. Considering that cytotoxic T-cell responses participate in the clearance of virus from recovered SARS patients and contribute to immunopathology in early stages of the disease [<a href="#CR21" rid="CR21" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978923">21</a>], one of the most attractive S protein-based strategies proposes eliciting a SARS-CoV CTL response to clear the infection. To this end, a detailed understanding of the S protein-mediated CTL response is essential.</p><p id="__p7">Development of effective treatments and vaccines against SARS-CoV depends upon the underlying mechanisms of various immune effectors in protective immunity and identification of the protective antigens recognized by each. Epitopes are the basic antigenic elements of virus structural proteins, which functionally induce the host cell-mediated immune response. Identification of the CTL-specific epitopes of SARS-CoV proteins could provide the basis for the development of SARS immunity-based treatments and aid in the understanding of mechanisms underlying SARS-CoV pathogenesis.</p><p id="__p8">HLA-A*0201 is expressed 39-46% of all major ethnicities [<a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978941">22</a>]. The identification of HLA-A*0201-restricted SARS-CoV/S CTL epitopes is an important contribution towards understanding the role of CTLs in SARS-CoV pathogenesis and protection. Currently, several CTL-specific SARS-CoV S protein epitopes have been identified in the context of HLA-A*0201, including S<sub>411-420</sub>, S<sub>787-795</sub>, S<sub>978-986</sub>, S<sub>1042-1050</sub>, S<sub>1167-1175</sub>, S<sub>1203-1211</sub> and SSp-1 [<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978901">23</a>&#x02013;<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978920">26</a>], and the H2 complex, including S<sub>366-374</sub>, S<sub>436-443</sub>, S<sub>525-532</sub> and S<sub>1031-1047</sub>[<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471686">18</a>, <a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471689">27</a>]. It is likely that additional S protein CTL epitopes exist. S protein is relatively large in size and usage of different detection methods may result in the identification of novel S protein-derived epitopes. In turn, this data will provide advances towards understanding the mechanisms of SARS-CoV infection, and contribute to the development of future SARS-CoV infection intervention strategies.</p><p id="__p9" class="p p-last">In this study, we identified a novel SARS/S-specific, HLA-A*0201-restricted epitope that was conserved among SARS-CoV strains. Based on a binding affinity-based prediction and a proteosomal cleavage site prediction, we constructed a panel of potential HLA-A*0201-restricted CTL peptides from the S protein. Each candidate peptide was evaluated for its binding affinity to HLA-A*0201 molecules using the T2 cell-peptide binding test. We then evaluated the ability of HLA-A*0201 binding peptides to provoke CTL responses in peripheral blood lymphocytes (PBL). PBL preparations from major histocompatibility complex (MHC)-matched healthy donors or HLA-A2.1/K<sup>b</sup> transgenic (Tg) mice, were incubated with dendritic cells (DCs) that had been pre-pulsed with the peptides of interest. We identified a novel SARS-CoV S protein-derived CTL epitope S<sub>(958-966)</sub>(VLNDILSRL) that was capable of priming the S protein-specific HLA-A2.1-restricted CTL response. The effective CTL response was evidenced by cell death of peptide-pulsed T2 and peptide-pulsed Jurkat-A2/K<sup>b</sup> cells. The findings of this study should provide insight into the immunological characteristics of spike protein and provide an alternative strategy for the future development of SARS-CoV S protein CTL epitope-based vaccines.</p></div><div id="Sec2" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec2title">Results</h2><div id="Sec3" class="sec sec-first"><h3 id="Sec3title">Selection of potential HLA-A*0201 binding peptides derived from SARS-CoV/S protein</h3><p id="__p10" class="p p-first">We selected candidate CTL epitopes derived from SARS-CoV S protein by two criteria: (<em>i</em>) conservation between different strains of SARS-CoV to encompass as many SARS-CoV strains as possible, and (<em>ii</em>) high representation in the general population, i.e., HLA-A*0201-restricted. After alignment of the amino acid residues of S protein with eighteen SARS-CoV strains (Figure <a href="/pmc/articles/PMC2792222/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure1),</span></span><span>1</span></a>), the BJ01 strain S protein was selected to predict the S protein specific, HLA-A*0201-restricted CTL epitopes. Based on the presence of HLA-A*0201 binding motifs and the cleavage sites for proteasomes and immunoproteasomes, eight candidate peptides were predicted and synthesized (Figure <a href="/pmc/articles/PMC2792222/figure/Fig1/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig1" rid-ob="ob-Fig1" co-legend-rid="lgnd_Fig1"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure1</span></span><span>1</span></a> and Table <a href="/pmc/articles/PMC2792222/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1),</span></span><span>1</span></a>), termed Sp1-8. These peptides were further verified as having an absence of shared sequence homology with the human or murine proteins using the BLAST search engine <a href="http://www.ncbi.nlm.nih.gov/blast/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ncbi.nlm.nih.gov/blast/</a>, to avoid any autoreactive response.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig1" co-legend-rid="lgnd_Fig1"><a href="/pmc/articles/PMC2792222/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140138195028800" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12865_2009_Article_281_Fig1_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12865_2009_Article_281_Fig1_HTML.jpg" src="/pmc/articles/PMC2792222/bin/12865_2009_Article_281_Fig1_HTML.jpg" /></div><div id="largeobj_idm140138195028800" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2792222/figure/Fig1/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig1"><div><a class="figpopup" href="/pmc/articles/PMC2792222/figure/Fig1/" target="figure" rid-figpopup="Fig1" rid-ob="ob-Fig1">Figure 1</a></div><!--caption a7--><div class="caption"><p id="__p11"><strong>Alignment of the putative amino acid sequences of S proteins from eighteen SARS-CoV strains</strong>. SARS-CoV strains with GenBank accession numbers of nucleotide sequence in parentheses were as follows: BJ01 (<a id="__tag_843978992" class="tag_hotlink" href="/nuccore/AY278488" ref="/nuccore/AY278488"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278488","term_id":"30275666","term_text":"AY278488"}}</span>AY278488</a>), BJ02 (<a id="__tag_843978964" class="tag_hotlink" href="/nuccore/AY278487" ref="/nuccore/AY278487"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278487","term_id":"31416292","term_text":"AY278487"}}</span>AY278487</a>), BJ03 (<a id="__tag_843978993" class="tag_hotlink" href="/nuccore/AY278490" ref="/nuccore/AY278490"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278490","term_id":"31416305","term_text":"AY278490"}}</span>AY278490</a>), CUHK-Su10 (<a id="__tag_843978977" class="tag_hotlink" href="/nuccore/AY282752" ref="/nuccore/AY282752"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY282752","term_id":"38304867","term_text":"AY282752"}}</span>AY282752</a>), CUHK-W1 (<a id="__tag_843978997" class="tag_hotlink" href="/nuccore/AY278554" ref="/nuccore/AY278554"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278554","term_id":"30027610","term_text":"AY278554"}}</span>AY278554</a>), Frankfurt 1 (<a id="__tag_843978994" class="tag_hotlink" href="/nuccore/AY291315" ref="/nuccore/AY291315"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY291315","term_id":"31581502","term_text":"AY291315"}}</span>AY291315</a>), GD01 (<a id="__tag_843978971" class="tag_hotlink" href="/nuccore/AY278489" ref="/nuccore/AY278489"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278489","term_id":"31416290","term_text":"AY278489"}}</span>AY278489</a>), HKU-39849 (<a id="__tag_843978976" class="tag_hotlink" href="/nuccore/AY278491" ref="/nuccore/AY278491"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278491","term_id":"30023963","term_text":"AY278491"}}</span>AY278491</a>), HSR 1 (<a id="__tag_843978975" class="tag_hotlink" href="/nuccore/AY323977" ref="/nuccore/AY323977"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY323977","term_id":"33115118","term_text":"AY323977"}}</span>AY323977</a>), Sin2500 (<a id="__tag_843978991" class="tag_hotlink" href="/nuccore/AY283794" ref="/nuccore/AY283794"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY283794","term_id":"30468042","term_text":"AY283794"}}</span>AY283794</a>), Sin2677 (<a id="__tag_843978984" class="tag_hotlink" href="/nuccore/AY283795" ref="/nuccore/AY283795"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY283795","term_id":"30468043","term_text":"AY283795"}}</span>AY283795</a>), Sin2679 (<a id="__tag_843978961" class="tag_hotlink" href="/nuccore/AY283796" ref="/nuccore/AY283796"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY283796","term_id":"30468044","term_text":"AY283796"}}</span>AY283796</a>), Sin2748 (<a id="__tag_843978988" class="tag_hotlink" href="/nuccore/AY283797" ref="/nuccore/AY283797"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY283797","term_id":"30468045","term_text":"AY283797"}}</span>AY283797</a>), Sin2774 (<a id="__tag_843978990" class="tag_hotlink" href="/nuccore/AY283798" ref="/nuccore/AY283798"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY283798","term_id":"37361915","term_text":"AY283798"}}</span>AY283798</a>), TOR2 (<a id="__tag_843978979" class="tag_hotlink" href="/nuccore/AY274119" ref="/nuccore/AY274119"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY274119","term_id":"30248028","term_text":"AY274119"}}</span>AY274119</a>), TW1 (<a id="__tag_843978972" class="tag_hotlink" href="/nuccore/AY291451" ref="/nuccore/AY291451"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY291451","term_id":"30698326","term_text":"AY291451"}}</span>AY291451</a>), TWC (<a id="__tag_843978980" class="tag_hotlink" href="/nuccore/AY321118" ref="/nuccore/AY321118"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY321118","term_id":"31873092","term_text":"AY321118"}}</span>AY321118</a>) and Urbani (<a id="__tag_843978985" class="tag_hotlink" href="/nuccore/AY278741" ref="/nuccore/AY278741"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278741","term_id":"30027617","term_text":"AY278741"}}</span>AY278741</a>). A dot among the individual sequences denoted nucleotides that are the same as the consensus. The candidate epitope peptides were shown in bold text.</p></div></div></div><!--table ft1--><!--table-wrap mode="anchored" t5--><div class="table-wrap table anchored whole_rhythm" id="Tab1"><h3>Table 1</h3><!--caption a7--><div class="caption"><p id="__p12">HLA-A*0201 binding affinity of candidate epitope peptides on T2 cells.</p></div><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140138194215840" class="xtable"><table frame="hsides" rules="groups" class="rendered small default_table"><thead><tr><th align="center" rowspan="1" colspan="1">Peptide</th><th align="center" rowspan="1" colspan="1">Denomination</th><th align="center" rowspan="1" colspan="1">Start position</th><th align="left" rowspan="1" colspan="1">Sequence</th><th align="center" rowspan="1" colspan="1">Score*</th><th align="center" rowspan="1" colspan="1">FI<sup>&#x02020;</sup></th></tr></thead><tbody><tr><td align="center" rowspan="1" colspan="1">No.1</td><td align="center" rowspan="1" colspan="1">Sp1</td><td align="center" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">FIFLLFLTL</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">0.5</td></tr><tr><td align="center" rowspan="1" colspan="1">No.2</td><td align="center" rowspan="1" colspan="1">Sp2</td><td align="center" rowspan="1" colspan="1">851</td><td align="left" rowspan="1" colspan="1">MIAAYTAAL</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">0.8</td></tr><tr><td align="center" rowspan="1" colspan="1">No.3</td><td align="center" rowspan="1" colspan="1">Sp3</td><td align="center" rowspan="1" colspan="1">404</td><td align="left" rowspan="1" colspan="1">VIADYNYKL</td><td align="center" rowspan="1" colspan="1">26</td><td align="center" rowspan="1" colspan="1">0.4</td></tr><tr><td align="center" rowspan="1" colspan="1">No.4</td><td align="center" rowspan="1" colspan="1">Sp4</td><td align="center" rowspan="1" colspan="1">208</td><td align="left" rowspan="1" colspan="1">DLPSGFNTL</td><td align="center" rowspan="1" colspan="1">24</td><td align="center" rowspan="1" colspan="1">0.1</td></tr><tr><td align="center" rowspan="1" colspan="1">No.5</td><td align="center" rowspan="1" colspan="1">Sp5</td><td align="center" rowspan="1" colspan="1">940</td><td align="left" rowspan="1" colspan="1">ALNTLVKQL</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.1</td></tr><tr><td align="center" rowspan="1" colspan="1">No.6</td><td align="center" rowspan="1" colspan="1">Sp6</td><td align="center" rowspan="1" colspan="1">1174</td><td align="left" rowspan="1" colspan="1">NLNESLIDL</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.1</td></tr><tr><td align="center" rowspan="1" colspan="1">No.7</td><td align="center" rowspan="1" colspan="1">Sp7</td><td align="center" rowspan="1" colspan="1">673</td><td align="left" rowspan="1" colspan="1">SIVAYTMSL</td><td align="center" rowspan="1" colspan="1">25</td><td align="center" rowspan="1" colspan="1">1.2</td></tr><tr><td align="center" rowspan="1" colspan="1">No.8</td><td align="center" rowspan="1" colspan="1">Sp8</td><td align="center" rowspan="1" colspan="1">958</td><td align="left" rowspan="1" colspan="1">VLNDILSRL</td><td align="center" rowspan="1" colspan="1">27</td><td align="center" rowspan="1" colspan="1">1.5</td></tr></tbody></table></div><div id="largeobj_idm140138194215840" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2792222/table/Tab1/?report=objectonly">Open in a separate window</a></div><div class="tblwrap-foot"><p id="__p13">* HLA-A*0201-binding motif score from algorithm SYFPEITHI &#x02265; 24. The eight peptides were also predicted and selected using ProPred1, in which the threshold of HLA-A2-binding motif is 4% and the threshold of proteasomal and immunoproteasomal cleavage site is 8%.</p><p id="__p14">&#x02020; Increase of HLA-A*0201 molecules on T2 cell surface. FI = [(mean FITC fluorescence with the given peptide - mean FITC fluorescence without peptide)/(mean FITC fluorescence without peptide)]. FI &#x0003e; 1.0 indicates high-affinity peptides; FI &#x02264; 1.0, low-affinity peptides. HLA-A*0201-restricted peptide S<sub>411-420</sub> was used as a positive control for HLA-A*0201-binding ability, while the H-2<sup>b</sup>-restricted peptide HBcAg<sub>(131-140)</sub> was used as a negative control.</p></div></div><p id="__p15" class="p p-last">To evaluate the binding affinity of these peptides to HLA-A*0201 molecules, a T2 cell-peptide binding test was used [<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978916">28</a>]. T2 cells lack the transporter associated with antigen processing (TAP), a key factor involved in endogenous antigen processing and presentation, causing the empty HLA-I molecules on the T2 cell surface to be very unstable and to degrade rapidly after cell surface presentation. However, when exogenous epitope peptides bind to the HLA-I molecules on the cell surface, they become stable [<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978900">28</a>, <a href="#CR29" rid="CR29" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978922">29</a>]. Accordingly, the peptide-induced upregulation of HLA-I on TAP-deficient T2 cells is used to monitor peptide binding to class I molecules, which then indicates the binding affinity of peptides to HLA-I molecules. Higher-affinity peptides will induce more HLA-A*0201 expression on the cell surface than will lower-affinity peptides. As shown in Table <a href="/pmc/articles/PMC2792222/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -2.5em;">Table1,</span></span><span>1</span></a>, of the eight candidate peptides only Sp5, Sp6, Sp7 and Sp8 were high-affinity epitopes (FI = 1.1, 1.1, 1.2 and 1.5, respectively). The positive control peptide, S<sub>411-420</sub>, bound HLA-A*0201 strongly (FI = 1.5), whereas no binding was observed with the negative control HBcAg<sub>(131-140)</sub> peptide (FI = 0.1).</p></div><div id="Sec4" class="sec"><h3 id="Sec4title"><em>Ex vivo</em> generation of peptide-specific CD8<sup>+</sup> CTLs from healthy human donor PBLs</h3><p id="__p16" class="p p-first-last">To investigate the capacity of candidate peptides to mobilize a human CTL repertoire, HLA-A2<sup>+</sup> PBLs from ten HLA-A2<sup>+</sup> donors were stimulated <em>in vitro</em> by DCs loaded with the eight candidate peptides, positive control peptides S<sub>411-420</sub>, or negative control peptides HBcAg<sub>(131-140)</sub>. T2 cells loaded with each of peptides were used as target cells in cytotoxicity assays. Of the eight peptides tested, Sp6, Sp7 and Sp8 induced more CD8<sup>+</sup> T-cells that specifically produced IFN-&#x003b3; in response to DCs pulsed with the relevant peptides or positive control peptide in comparison to other groups (Figure <a href="/pmc/articles/PMC2792222/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2A).</span></span><span>2A</span></a>). Furthermore, these CD8<sup>+</sup> T cells could lyse the T2 cells loaded with relevant peptides or positive control peptide more efficiently than other groups (Figure <a href="/pmc/articles/PMC2792222/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2B).</span></span><span>2B</span></a>). The cytolysis observed were specific because the CTLs could not lyse T2 cells loaded with irrelevant peptides (Figure <a href="/pmc/articles/PMC2792222/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2B).</span></span><span>2B</span></a>). Due to the limited induction of IFN-&#x003b3; secreting T cell frequency and the low CTL cytolysis ability, groups other than Sp6, Sp7 and Sp8 were excluded from further study. The <em>ex vivo</em> results showed the existence of functional anti-SARS-CoV/S CTL precursors in the peripheral T cell repertoire of healthy donors. Furthermore, SARS-CoV/S-derived peptides Sp6, Sp7 and Sp8 could not only induce the increased S protein specific IFN-&#x003b3; secreting T cell frequency but also the enhanced cytolytic capacity of these CTLs.</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig2" co-legend-rid="lgnd_Fig2"><a href="/pmc/articles/PMC2792222/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140138190967792" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12865_2009_Article_281_Fig2_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12865_2009_Article_281_Fig2_HTML.jpg" src="/pmc/articles/PMC2792222/bin/12865_2009_Article_281_Fig2_HTML.jpg" /></div><div id="largeobj_idm140138190967792" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2792222/figure/Fig2/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig2"><div><a class="figpopup" href="/pmc/articles/PMC2792222/figure/Fig2/" target="figure" rid-figpopup="Fig2" rid-ob="ob-Fig2">Figure 2</a></div><!--caption a7--><div class="caption"><p id="__p17"><strong>Identification of candidate epitope peptides</strong>\n<strong><em>ex vivo</em></strong>. Panel A, Identification of candidate peptides with the PBLs of HLA-A2.1<sup>+</sup> healthy donors by ELISPOT assay. Autologous DCs were pulsed with 20 &#x003bc;g/ml of the indicated peptides and then used as stimulators for HLA-A2.1<sup>+</sup> PBLs in an IFN-&#x003b3; release assay. Resulting CTLs were tested for IFN-&#x003b3; release using an ELISPOT assay. Results presented are from three independent experiments and values are expressed as means &#x000b1; SD. PC, positive control peptide S<sub>411-420</sub>; NC, negative control peptide HBcAg<sub>(131-140)</sub>. Panel B, Specific cytolysis of human CTLs induced by peptides-loaded DCs <em>ex vivo</em>. Peptide-specific CTLs were generated from the PBLs of HLA-A2.1<sup>+</sup> healthy donors through two rounds of stimulation with eight different peptide-pulsed DCs, respectively. Resulting CTLs were tested for peptide-specific lysis using a standard 4-hour <sup>51</sup>Cr release assay. Results presented are from three independent experiments. Data is expressed as means &#x000b1; SD. E/T ratio, effector cell to target cell ratio.</p></div></div></div></div><div id="Sec5" class="sec sec-last"><h3 id="Sec5title"><em>In vivo</em> induction of peptide-specific CD8<sup>+</sup> CTLs in HLA-A2.1/K<sup>b</sup> transgenic mice</h3><p id="__p18" class="p p-first">To further address whether the immunogenic candidate peptide is naturally processed and presented, HLA-A2.1/K<sup>b</sup> transgenic mice were immunized with S/pVAX1 plasmid containing a full-length cDNA encoding the SARS-CoV/S protein. Splenocytes were collected from mice seven days after four weekly injections with S/pVAX1, and re-stimulated <em>ex vivo</em> by mouse bone marrow-derived DCs loaded with the candidate peptides, the positive peptide S<sub>411-420</sub>, the irrelevant peptides HBcAg<sub>(131-140)</sub>, or DCs alone, for an additional 6 days. Investigation of IFN-&#x003b3; production and the cytolytic ability of the effector CTL cells were carried out following the re-stimulation. The J(A2/k<sup>b</sup>) cells loaded with the corresponding peptides were used as targets in cytotoxicity assays. As shown in Figure <a href="/pmc/articles/PMC2792222/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">Figure3A,</span></span><span>3A</span></a>, CTLs from S/pVAX1-immunized mice were able to lyse three candidate peptides-pulsed J(A2/k<sup>b</sup>) cells but did not lyse J(A2/k<sup>b</sup>) cells alone or J(A2/k<sup>b</sup>) cells loaded with irrelevant peptide HBcAg<sub>(131-140)</sub> at any E/T ratio. Of the three candidate peptides tested, Sp8 exhibited the most lytic capacity at each E/T ratio, which was comparable to the positive control peptide (Figure <a href="/pmc/articles/PMC2792222/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3A</span></span><span>3A</span></a>).</p><!--fig ft0--><!--fig mode=article f1--><div class="fig iconblock whole_rhythm clearfix" id="Fig3" co-legend-rid="lgnd_Fig3"><a href="/pmc/articles/PMC2792222/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3"><!--fig/graphic|fig/alternatives/graphic mode="anchored" m1--><div data-largeobj="" data-largeobj-link-rid="largeobj_idm140138197820016" class="figure"><img class="fig-image" alt="An external file that holds a picture, illustration, etc.&#10;Object name is 12865_2009_Article_281_Fig3_HTML.jpg" title="An external file that holds a picture, illustration, etc.&#10;Object name is 12865_2009_Article_281_Fig3_HTML.jpg" src="/pmc/articles/PMC2792222/bin/12865_2009_Article_281_Fig3_HTML.jpg" /></div><div id="largeobj_idm140138197820016" class="largeobj-link align_right" style="display: none"><a target="object" href="/pmc/articles/PMC2792222/figure/Fig3/?report=objectonly">Open in a separate window</a></div></a><div class="icnblk_cntnt" id="lgnd_Fig3"><div><a class="figpopup" href="/pmc/articles/PMC2792222/figure/Fig3/" target="figure" rid-figpopup="Fig3" rid-ob="ob-Fig3">Figure 3</a></div><!--caption a7--><div class="caption"><p id="__p19"><strong>SARS-CoV S protein specific CTLs in DNA vaccine-immunized HLA-A2.1/K</strong><sup><strong>b</strong></sup><strong>-Tg mice</strong>. Panel A, Specific cytolysis of CTLs induced by the candidate peptides in HLA-A2.1/K<sup>b</sup> transgenic mice. Splenic single-cell suspensions from S/pVAX1-immunized mice were harvested and re-stimulated with peptide-pulsed mouse bone marrow-derived DCs <em>in vitro</em> to act as effector cells. The J(A2/kb) cells pulsed with peptides were used as targets. Cytotoxic activity was determined in a standard <sup>51</sup>Cr release assay at the indicated E/T ratios. Panel B, Frequency of IFN-&#x003b3; producing cells induced by the indicated SARS S-derived candidate peptides in HLA-A2.1/K<sup>b</sup> transgenic mice. Bulk CTLs from immunized mice were co-cultured with autologous DCs in the presence of each peptide at a final concentration of 20 &#x003bc;g/ml. The secretion of peptide-specific IFN-&#x003b3; was analyzed using ELISPOT assays. Results presented were from three independent experiments. Data is expressed as means &#x000b1; SD. E/T ratio, effector cell to target cell ratio.</p></div></div></div><p id="__p20" class="p p-last">In accordance with results from the cytolytic assays, bulk CTLs released IFN-&#x003b3; only in response to DCs pulsed with Sp6, Sp7, Sp8 and the positive control peptide, but not to those pulsed with irrelevant peptide HBcAg<sub>(131-140)</sub> or DCs alone (Figure <a href="/pmc/articles/PMC2792222/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3B).</span></span><span>3B</span></a>). Again, among the three tested candidate peptides, Sp8 released the most IFN-&#x003b3; following peptide stimulation (Figure <a href="/pmc/articles/PMC2792222/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3B</span></span><span>3B</span></a>).</p></div></div><div id="Sec6" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec6title">Discussion</h2><p id="__p21" class="p p-first">It is known that SARS-CoV can induce a strong specific CTL response in infected patients, besides high titres of neutralizing antibodies [<a href="#CR10" rid="CR10" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978939">10</a>, <a href="#CR11" rid="CR11" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978902">11</a>]. Furthermore, the CTL response levels correlate with disease outcome [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978896">12</a>], suggesting CTL response is crucial for the clearance of SARS-CoV. Among all the encoded proteins in the SARS-CoV genome, S protein is currently considered the most important target to prime the host immune response [<a href="#CR12" rid="CR12" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978949">12</a>, <a href="#CR16" rid="CR16" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978903">16</a>&#x02013;<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471682">18</a>]. It has been reported that an inflammatory cell influx of airway macrophages and a massive release of cytokines occur during the peak of SARS infection [<a href="#CR30" rid="CR30" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471687">30</a>]. Thus, it is reasonable to investigate the underlying mechanism of specific CTL response induced by SARS-CoV S protein during SARS-CoV infection which may have a positive role in SARS-CoV clearance or a negative role in SARS-CoV immunopathogenesis.</p><p id="__p22">In this study, we predicted and validated a novel CTL epitope of SARS-CoV S protein. We used two prediction systems to identify candidate CTL epitopes of S protein (i.e., HLA-A2-binding peptide prediction method combined with a proteosomal cleavage site prediction system) to improve prediction accuracy. The eight predicted peptides were then verified via MHC peptide binding assay (Table <a href="/pmc/articles/PMC2792222/table/Tab1/" target="table" class="fig-table-link figpopup" rid-figpopup="Tab1" rid-ob="ob-Tab1" co-legend-rid=""><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3em;">(Table1).</span></span><span>1</span></a>). Among the eight candidate peptides, Sp5, Sp6, Sp7 and Sp8 exhibited the highest capacity to induce more potent CTLs secreting IFN-&#x003b3; and to lyse target cells from HLA-A*0201-matched healthy donor PBLs (Figure <a href="/pmc/articles/PMC2792222/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2).</span></span><span>2</span></a>). Further <em>in vivo</em> investigation showed that plasmid encoding the full-length SARS-CoV S gene elicited strong CTL response in HLA-A2.1/K<sup>b</sup> transgenic mice. These CTLs could produce substantial amounts of IFN-&#x003b3; and kill target cells in a peptide-specific and HLA-A*0201-restricted manner (Figure <a href="/pmc/articles/PMC2792222/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3),</span></span><span>3</span></a>), suggesting the predicted candidate peptides were native epitopes, capable of priming CTL responses <em>in vivo</em>. We found that candidate peptide Sp8 held the greatest ability to secrete IFN-&#x003b3; and kill target cells <em>in vivo</em> (Figure <a href="/pmc/articles/PMC2792222/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3).</span></span><span>3</span></a>). Another candidate peptide, Sp7, failed to induce the most potent peptide specific CTLs in Tg mice (Figure <a href="/pmc/articles/PMC2792222/figure/Fig3/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig3" rid-ob="ob-Fig3" co-legend-rid="lgnd_Fig3"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure3),</span></span><span>3</span></a>), despite it having had the highest such ability in comparison to the rest of the <em>in vitro</em> stimulation set (Figure <a href="/pmc/articles/PMC2792222/figure/Fig2/" target="figure" class="fig-table-link figpopup" rid-figpopup="Fig2" rid-ob="ob-Fig2" co-legend-rid="lgnd_Fig2"><span style="position: relative;text-decoration:none;">&#x200B;<span class="figpopup-sensitive-area" style="left: -3.5em;">(Figure2),</span></span><span>2</span></a>), indicating the need for candidate peptides to be biofunctionally validated <em>in vivo</em>.</p><p id="__p23">To date, several CTL epitopes of SARS-CoV S protein have been identified in the context of HLA-A*0201, including S<sub>411-420</sub>, S<sub>787-795</sub>, S<sub>978-986</sub>, S<sub>1042-1050</sub>, S<sub>1167-1175</sub>, S<sub>1203-1211</sub> and SSp-1 [<a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978927">23</a>&#x02013;<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978913">26</a>], or of the H2 complex, including S<sub>366-374</sub>, S<sub>436-443</sub>, S<sub>525-532</sub> and S<sub>1031-1047</sub>[<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471678">18</a>, <a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471685">27</a>]. In this study, we predicted and validated a novel CTL epitope of SARS-CoV S protein, Sp8 (S<sub>958</sub>, VLNDILSRL). This may be due to the unique predictive methods used in our study. We combined strategies for prediction (i.e., HLA-A2-binding peptide prediction method combined with a proteosomal cleavage site prediction system). Previous studies used single methods, such as HLA peptide binding prediction or overlapping peptide strategy [<a href="#CR18" rid="CR18" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471679">18</a>, <a href="#CR23" rid="CR23" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978935">23</a>&#x02013;<a href="#CR27" rid="CR27" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_848471683">27</a>], suggesting different prediction strategies might lead to different results. In any case, the predicted candidate peptides require additional validation methods to ensure accuracy.</p><p id="__p24">In our study, we also determined that among the eight peptides we predicted, four could potent prime CTLs to produce significant IFN-&#x003b3; and lyse target cells; although, Sp8 peptide exhibited the most potency for CTL priming. However, Zhou <em>et al</em>. reported that they only found one predicted peptide that could stimulate IFN-&#x003b3; secretion and target cell lysis [<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978950">26</a>]. This may reflect the different stimulators used in these studies; Zhou used peptides to stimulate the effector cells directly while we used DCs loaded with the candidate peptides.</p><p id="__p25" class="p p-last">We argue for the use of DCs as stimulator cells in <em>ex vivo</em> study because DCs are the most potent APCs for priming T cells, and they not only present peptides to T cells but also provide many important co-stimulatory signals. Moreover, under <em>in vivo</em> conditions DCs present peptides to T cells in the context of MHC molecules. Thus, using DCs as <em>ex vivo</em> stimulator cells most closely mimics the <em>in vivo</em> context.</p></div><div id="Sec7" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec7title">Conclusion</h2><p id="__p26" class="p p-first-last">Our study has identified a novel conserved HLA-A*0201-restricted epitope from the spike protein of SARS-CoV. We propose that the newly identified epitope could be used for evaluation of SARS-CoV-specific CD8<sup>+</sup> T-cell responses during the course of SARS infection and treatment. This epitope should also aid in the characterization of virus control mechanisms and immunopathology of SARS-CoV infection. Ultimately, our findings may be relevant to the development of ethnically unbiased, widely applicable immunotherapeutic approaches for SARS disease.</p></div><div id="Sec8" class="tsec sec"><h2 class="head no_bottom_margin" id="Sec8title">Methods</h2><div id="Sec9" class="sec sec-first"><h3 id="Sec9title">Sequence alignments</h3><p id="__p27" class="p p-first-last">Nucleotide sequences of SARS-CoV strains were analyzed using BioEdit version 5.0.9 software suite. The corresponding amino acid sequences of S protein were then aligned with Clustal W <a href="http://www.ebi.ac.uk/clustalw/" data-ga-action="click_feat_suppl" ref="reftype=extlink&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CBody&amp;TO=External%7CLink%7CURI" target="_blank">http://www.ebi.ac.uk/clustalw/</a>. SARS-CoV strains used were as follows, with the nucleotide sequence GenBank accession numbers in parentheses: BJ01 (<a id="__tag_843978974" class="tag_hotlink" href="/nuccore/AY278488" ref="/nuccore/AY278488"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278488","term_id":"30275666","term_text":"AY278488"}}</span>AY278488</a>), BJ02 (<a id="__tag_843978963" class="tag_hotlink" href="/nuccore/AY278487" ref="/nuccore/AY278487"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278487","term_id":"31416292","term_text":"AY278487"}}</span>AY278487</a>), BJ03 (<a id="__tag_843978965" class="tag_hotlink" href="/nuccore/AY278490" ref="/nuccore/AY278490"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278490","term_id":"31416305","term_text":"AY278490"}}</span>AY278490</a>), CUHK-Su10 (<a id="__tag_843978966" class="tag_hotlink" href="/nuccore/AY282752" ref="/nuccore/AY282752"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY282752","term_id":"38304867","term_text":"AY282752"}}</span>AY282752</a>), CUHK-W1 (<a id="__tag_843978995" class="tag_hotlink" href="/nuccore/AY278554" ref="/nuccore/AY278554"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278554","term_id":"30027610","term_text":"AY278554"}}</span>AY278554</a>), Frankfurt 1 (<a id="__tag_843978973" class="tag_hotlink" href="/nuccore/AY291315" ref="/nuccore/AY291315"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY291315","term_id":"31581502","term_text":"AY291315"}}</span>AY291315</a>), GD01 (<a id="__tag_843978996" class="tag_hotlink" href="/nuccore/AY278489" ref="/nuccore/AY278489"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278489","term_id":"31416290","term_text":"AY278489"}}</span>AY278489</a>), HKU-39849 (<a id="__tag_843978981" class="tag_hotlink" href="/nuccore/AY278491" ref="/nuccore/AY278491"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278491","term_id":"30023963","term_text":"AY278491"}}</span>AY278491</a>), HSR 1 (<a id="__tag_843978960" class="tag_hotlink" href="/nuccore/AY323977" ref="/nuccore/AY323977"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY323977","term_id":"33115118","term_text":"AY323977"}}</span>AY323977</a>), Sin2500 (<a id="__tag_843978969" class="tag_hotlink" href="/nuccore/AY283794" ref="/nuccore/AY283794"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY283794","term_id":"30468042","term_text":"AY283794"}}</span>AY283794</a>), Sin2677 (<a id="__tag_843978982" class="tag_hotlink" href="/nuccore/AY283795" ref="/nuccore/AY283795"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY283795","term_id":"30468043","term_text":"AY283795"}}</span>AY283795</a>), Sin2679 (<a id="__tag_843978999" class="tag_hotlink" href="/nuccore/AY283796" ref="/nuccore/AY283796"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY283796","term_id":"30468044","term_text":"AY283796"}}</span>AY283796</a>), Sin2748 (<a id="__tag_843978967" class="tag_hotlink" href="/nuccore/AY283797" ref="/nuccore/AY283797"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY283797","term_id":"30468045","term_text":"AY283797"}}</span>AY283797</a>), Sin2774 (<a id="__tag_843978983" class="tag_hotlink" href="/nuccore/AY283798" ref="/nuccore/AY283798"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY283798","term_id":"37361915","term_text":"AY283798"}}</span>AY283798</a>), TOR2 (<a id="__tag_843978968" class="tag_hotlink" href="/nuccore/AY274119" ref="/nuccore/AY274119"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY274119","term_id":"30248028","term_text":"AY274119"}}</span>AY274119</a>), TW1 (<a id="__tag_843979000" class="tag_hotlink" href="/nuccore/AY291451" ref="/nuccore/AY291451"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY291451","term_id":"30698326","term_text":"AY291451"}}</span>AY291451</a>), TWC (<a id="__tag_843978989" class="tag_hotlink" href="/nuccore/AY321118" ref="/nuccore/AY321118"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY321118","term_id":"31873092","term_text":"AY321118"}}</span>AY321118</a>) and Urbani (<a id="__tag_843978987" class="tag_hotlink" href="/nuccore/AY278741" ref="/nuccore/AY278741"><span class="tag-json" style="display:none">{"type":"entrez-nucleotide","attrs":{"text":"AY278741","term_id":"30027617","term_text":"AY278741"}}</span>AY278741</a>).</p></div><div id="Sec10" class="sec"><h3 id="Sec10title">Peptides</h3><p id="__p28" class="p p-first">To identify potential HLA-A*0201-binding peptides within the S protein of the SARS-CoV (BJ01) strain, a combination of two computer algorithms was utilized. The predictive algorithm, "ProPred1"[<a href="#CR31" rid="CR31" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978912">31</a>], is a matrix-based method that allows the prediction of MHC binding sites in an antigenic sequence for 47 MHC class-I alleles. We restricted our analysis to the HLA-A2 allele, since it is prevalent in a large percentage of all major ethnicities and it is the most extensively studied HLA class-I antigen [<a href="#CR22" rid="CR22" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978933">22</a>]. ProPred1 also allows the prediction of the standard proteasomal and immunoproteasomales cleavage sites in an antigenic sequence. The simultaneous prediction of MHC binding and proteasomal cleavage sites in an antigenic sequence leads to the identification of potential T-cell epitopes. The second algorithm, "SYFPEITHI", was developed by H. G. Rammensee <em>et al</em>[<a href="#CR32" rid="CR32" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978943">32</a>], and ranks peptides according to a score that takes into account the presence of primary and secondary MHC-binding anchor residues. The 9 mer peptides with a score exceeding 24 were selected in "SYFPEITHI".</p><p id="__p29" class="p p-last">The amino acid sequence of SARS-CoV/S (BJ01) was analyzed on both of the computer programs for the existence of 9-amino acid peptides predicted to bind to HLA-A2. The candidates peptides were synthesized at SHENYOU Biotech (Shanghai, China) and purified by reverse phase HPLC to &#x0003e; 95%, as confirmed by mass spectrometry. The published HLA-A*0201-restricted peptide S<sub>411-420</sub> (KLPDDFMGCV) derived from the S protein of SARS-CoV [<a href="#CR26" rid="CR26" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978907">26</a>] was used as a positive control for HLA-A*0201-binding ability, and the HBcAg-derived H-2<sup>b</sup>-restricted peptide HBcAg<sub>(131-140)</sub> (AYRPPNAPIL) was used as a negative control. Lyophilized peptides were dissolved in PBS at a concentration of 1 mg/ml and stored in aliquots at -20&#x000b0;C.</p></div><div id="Sec11" class="sec"><h3 id="Sec11title">Cells and Cell Culture</h3><p id="__p30" class="p p-first">HLA-A2<sup>+</sup> individuals were selected by flow cytometry screening using the anti-HLA-A2 monoclonal antibody BB7.2. Buffy coats from HLA-A2<sup>+</sup> normal donors were purchased from Southwest Hospital (Third Military Medical University, Chongqing, China). PBL from an HLA-A2<sup>+</sup> healthy donor were separated on Ficoll-Hypaque density gradients (TBD, Inc, Tianjin, China), washed three times in phosphate-buffered saline (PBS), resuspended in RPMI1640 medium (Gibco, BRL) supplemented with L-glutamine (10 mg/ml), penicillin (5 &#x000d7; 10<sup>4</sup>U/L), streptomycin (50 mg/L) and 10% fetal calf serum (FCS), and plated in 6-well plates at 4 &#x000d7; 10<sup>6</sup> cells per well.</p><p id="__p31" class="p p-last">Human TAP-deficient T2 cell line and BB7.2 cell line producing mAb against HLA-A2 were purchased from American Type Culture Collection. T2 cell line was maintained in RPMI1640 medium supplemented with 20% fetal bovine serum and 100 &#x003bc;g/ml penicillin/streptomycin. BB7.2 cell line was maintained in DMEM containing 10% FCS, 4 &#x003bc;g/L glucose, penicillin (5 &#x000d7; 10<sup>4</sup>U/L) and streptomycin (50 mg/L). Jurkat-A2/K<sup>b</sup> cells, a generous gift from Dr. W. Martin Kast (the Norris Comprehensive Cancer Center, Los Angeles, CA) and Dr. Jehad Charo (the Max Delbruck Center for Medicine, Berlin, Germany), were transfected with the HLA chimeric molecule containing the &#x003b1;1 and &#x003b1;2 domains from human HLA-A*0201 and &#x003b1;3 from mouse H-2K<sup>b</sup>, to serve as a model system of HLA restricted responses [<a href="#CR33" rid="CR33" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978926">33</a>]. The Jurkat-A2/K<sup>b</sup> (J(A2/kb)) cell line was maintained in RPMI1640 medium (Gibco, BRL) plus 10% calf serum and supplemented with 4 &#x003bc;g/L glucose, penicillin (5 &#x000d7; 10<sup>4</sup> U/L) and streptomycin (50 mg/L). All cell lines mentioned above were kept at 37&#x000b0;C in a humidified atmosphere of 5% CO<sub>2</sub> in air.</p></div><div id="Sec12" class="sec"><h3 id="Sec12title">Animals</h3><p id="__p32" class="p p-first-last">HLA-A2.1/K<sup>b</sup> transgenic (Tg) mice were purchased from the Jackson Laboratory (Bar harbor, ME). For experimental purposes, six to eight week-old mice were used. Cell surface HLA-A*0201 expression was assessed by flow cytometry using fluorescein isothiocyanate (FITC)-labeled HLA-A2-specific mAb BB7.2 (Sterotec Ltd, Oxford, UK). Mice were kept in SPF animal care facilities and all experiments were performed according to the guidelines in the Institutional Animal Committee of TMMU.</p></div><div id="Sec13" class="sec"><h3 id="Sec13title">Binding assay of candidate peptides to HLA-A2</h3><p id="__p33" class="p p-first-last">All candidate peptides were tested individually for their capacity to bind to HLA-A2 molecules on the surface of human TAP-deficient T2 cells [<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978908">28</a>]. Briefly, T2 cells were incubated with 20 &#x003bc;g/ml candidate peptides and 3 &#x003bc;g/ml human &#x003b2;2-microglobulin (Sigma, St Louis, MO) in serum-free RPMI1640 for 18 hours at 37&#x000b0;C in a 5% CO<sub>2</sub> atmosphere. Expression of HLA-A*0201 on T2 cells was then determined by staining with FITC-conjugated anti-HLA-A2 mAb BB7.2 and data analyzed using a FACSCalibur flow cytometer (Becton Dickinson, Mountain View, CA) and CellQuest software (Becton Dickinson). The published peptide S<sub>411-420</sub> and HBcAg<sub>(131-140)</sub> served as positive and negative control, respectively. The former is known to bind to HLA-A2 molecule with high affinity, the latter has been identified as mouse H2K<sup>d</sup> epitope that has little binding affinity with HLA-A2 molecule. The fluorescence index (FI) was calculated as follows: FI = [(mean FITC fluorescence with the given peptide - mean FITC fluorescence without peptide)/(mean FITC fluorescence without peptide)]. Peptides with an FI more than 1 were regarded as high-affinity epitopes.</p></div><div id="Sec14" class="sec"><h3 id="Sec14title">Generation of CTLs in healthy donors</h3><p id="__p34" class="p p-first-last">Human peripheral blood monocyte-derived DCs were generated as described previously [<a href="#CR28" rid="CR28" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978940">28</a>] with minor modifications. Briefly, human PBLs were suspended in serum-free RPMI1640 and allowed to adhere to 6-well plates at a final concentration of 1 &#x000d7; 10<sup>7</sup> cells/3 ml/well and cultured in 5% CO2 at 37&#x000b0;C. After 2 hours, non-adherent cells were gently removed with warm medium. The resulting adherent cells were cultured in RPMI1640 medium supplemented with 10% FCS, 20 ng/ml recombinant human interleukin-4 (IL-4) (R&#x00026;D Systems, Minneapolis, MN) and 800 U/ml recombinant human granulocyte-macrophage colony stimulating factor (GM-CSF; Sandoz, Basel, Switzerland) in 5% CO<sub>2</sub> at 37&#x000b0;C. Every two days, one-half of the medium was replaced by fresh medium containing double concentration of GM-CSF and IL-4 as indicated above. Cell suspensions were collected for analysis of surface phenotype at different stages of development. After five days of culture, DCs were harvested for subsequent experiments (90% pure as confirmed by analysis of relatively DC-specific phenotype and with a typical DC morphology). 10 ng/ml recombinant human tumor necrosis factor (TNF-&#x003b1;, Peprotech, Rocky Hill, NJ) was added to the medium to induce phenotypic and functional maturation. Then, 48 hours later, DCs were used to prime autologous PBLs as follows, DCs were pulsed with 20 &#x003bc;g/ml peptide in the presence of 3 &#x003bc;g/ml &#x003b2;2-microglobulin at 37&#x000b0;C for 5 hours and irradiated at 30 Gy before use. PBLs (2 &#x000d7; 10<sup>6</sup> cells/3 ml culture medium) were co-cultured with 2 &#x000d7; 10<sup>5</sup> peptide-pulsed irradiated autologous DCs in a 6-well plate in the presence of 10 ng/ml recombinant human interleukin-7 (IL-7; Peprotech). After 24 to 48 hours 20 IU/ml human interleukin-2 (IL-2, Sigma) was added to the culture medium. Lymphocytes were re-stimulated each week in the same manner. Three days after the second round of re-stimulation, induced cells were harvested and tested by cytokine determination and cytotoxicity assays.</p></div><div id="Sec15" class="sec"><h3 id="Sec15title">Generation of CTLs in HLA-A2.1/K<sup>b</sup> transgenic mice</h3><p id="__p35" class="p p-first-last">A plasmid S/pVAX1 encoding SARS-CoV S protein was constructed and used to immunize the HLA-A2.1/K<sup>b</sup> transgenic mice at a dose of 100 &#x003bc;g (in 100 &#x003bc;l of PBS) of plasmid S/pVAX1 by injection into tibialis anterior muscles. Mice were re-inoculated four times every seven days under the same conditions. In this study, bone marrow-derived DCs were generated from transgenic mice as previously described [<a href="#CR34" rid="CR34" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978921">34</a>, <a href="#CR35" rid="CR35" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978904">35</a>] with some modification. DCs were pulsed with 20 &#x003bc;g/ml peptide in the presence of 3 &#x003bc;g/ml &#x003b2;2-microglobulin at 37&#x000b0;C for 5 hours and irradiated at 30 Gy before use. Spleens were aseptically removed after the final scheduled immunization. Splenic single-cell suspensions were then harvested and cultured in 6-well plates at a density of 1 &#x000d7; 10<sup>7</sup> cells/3 ml/well, in the presence of 1 &#x000d7; 10<sup>5</sup> peptide-loaded irradiated syngeneic DCs. On day six of culture, induced cells were harvested and tested by cytokine determination and cytotoxicity assays.</p></div><div id="Sec16" class="sec"><h3 id="Sec16title">Cytotoxicity assays</h3><p id="__p36" class="p p-first">Cytotoxic activity of CTLs was determined in a standard 4-hour <sup>51</sup>Cr release assay as previously described [<a href="#CR36" rid="CR36" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978918">36</a>] with some modification. In human cytotoxicity assays, DCs derived from a healthy HLA-A2<sup>+</sup> donor were incubated with each of candidate peptides and used to stimulate autologous healthy HLA-A2<sup>+</sup> donor PBLs. T2 cells loaded with the relevant peptides were used as target cells in cytotoxicity assays. As a positive control group, HLA-A2<sup>+</sup> PBLs were stimulated with S<sub>411-420</sub>-pulsed autologous DCs. HLA-A2<sup>+</sup> PBLs stimulated with HBcAg<sub>(131-140)</sub>-pulsed autologous DCs served as the negative control group. In DNA-immunized mice cytotoxicity assays, the target cells were the J(A2/kb) cells loaded with the candidate peptides, the positive control peptide S<sub>411-420</sub>, the irrelevant peptides HBcAg<sub>(131-140)</sub>, and J(A2/kb) cells alone.</p><p id="__p37" class="p p-last">First, T2 cells and/or J(A2/kb) cells were loaded with 20 &#x003bc;g/ml peptides and 3 &#x003bc;g/ml human &#x003b2;2-microglobulins and incubated at 37&#x000b0;C for 2 hours. Then peptide-pulsed T2 cells and/or J(A2/kb) cells were labeled with <sup>51</sup>Cr sodium chromate (Na<sup>51</sup>CrO<sub>4</sub>, Perkin-Elmer Life Science, Boston, MA) for 90 minutes at 37&#x000b0;C. <sup>51</sup>Cr-labeled target cells were washed three times and mixed with graded doses of effectors in 96-well plates. After incubation at 37&#x000b0;C for 4 hours, a total of 100 &#x003bc;l supernatant was collected from each well and radioactivity was counted with a gamma counter. Each assay was performed in triplicate. Percent specific lysis was determined according to the following formula: percent specific lysis = [(mean experimental cpm - mean spontaneous cpm)/(mean maximum cpm - mean spontaneous cpm)] &#x000d7; 100%. Spontaneous and maximum releases were determined by incubating the labeled targets with medium alone or 1 M HCl, respectively. Spontaneous release was always &#x0003c; 15% of maximum release.</p></div><div id="Sec17" class="sec sec-last"><h3 id="Sec17title">Enzyme-linked immunosorbent spot (ELISPOT) assay</h3><p id="__p38" class="p p-first-last">ELISPOT assay was performed using a commercially available kit (U-CyTech, Netherlands) according to the manufacturer\'s instructions and published literature [<a href="#CR37" rid="CR37" class=" bibr popnode tag_hotlink tag_tooltip" id="__tag_843978928">37</a>] with some modification. Autologous DCs were pulsed with 20 &#x003bc;g/ml candidate peptides and used as stimulators for HLA-A2.1<sup>+</sup> PBLs from the immunized mice. Effector cells (1 &#x000d7; 10<sup>5</sup>) and stimulator cells (1 &#x000d7; 10<sup>5</sup>) were seeded into 96-well polyvinylidene fluoride (PVDF)-backed microplates pre-coated with anti-IFN-&#x003b3; mAb. After incubation at 37&#x000b0;C for 48 hours, cells were removed and plates processed as described in the instruction. Resulting spots were counted with a stereomicroscope (Carl Zeiss, Thornwood, NY) under magnifications of &#x000d7;20 to &#x000d7;40. Only brown and/or blue colored spots with fuzzy borders were scored as spot-forming cells (SFCs). As a positive control, S<sub>411-420</sub>-loaded DCs were used as stimulator cells. The HBcAg<sub>(131-140)</sub>-loaded DCs, DCs alone, and medium were used as negative controls. Negative control values were always &#x0003c; 20 SFC per 10<sup>6</sup> input cells. Results were considered positive when at least 120 SFC/10<sup>6</sup> PBL were detected. Each assay was run in triplicate and results were representative of three experiments.</p></div></div><div id="idm140138192020704" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140138192020704title">Acknowledgements</h2><div class="sec"><p id="__p45">This work was supported by grants from the National Key Basic Research Program of China (2003CB514108, 2001CB510001), and the National Natural Science Foundation of China (NSFC, 30490240). We thank Dr W. Martin Kast (the Norris Comprehensive Cancer Center, Los Angeles, CA) and Dr. Jehad Charo (the Max-Delbruck-Center for Medicine, Berlin) for generously providing us with Jurkat-A2/K<sup>b</sup> cell lines, respectively.</p></div></div><div id="App1" class="tsec sec headless whole_rhythm"><!--/article/back/app-group/app/--><div id="Sec18" class="sec sec-first"><h3 id="Sec18title">Authors&#x02019; original submitted files for images</h3><p id="__p39" class="p p-first-last">Below are the links to the authors&#x02019; original submitted files for images.<span class="sup-box" id="MOESM1"><a href="/pmc/articles/PMC2792222/bin/12865_2009_281_MOESM1_ESM.eps" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 1</a><sup>(6.7M, eps)</sup></span><span class="sup-box" id="MOESM2"><a href="/pmc/articles/PMC2792222/bin/12865_2009_281_MOESM2_ESM.eps" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 2</a><sup>(4.2M, eps)</sup></span><span class="sup-box" id="MOESM3"><a href="/pmc/articles/PMC2792222/bin/12865_2009_281_MOESM3_ESM.eps" data-ga-action="click_feat_suppl">Authors&#x02019; original file for figure 3</a><sup>(4.9M, eps)</sup></span></p></div></div><div id="idm140138196457744" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140138196457744title">Footnotes</h2><!--back/fn-group--><div class="fm-sec half_rhythm small"><p class="fn sec" id="idm140138196457616"><p id="__p43" class="p p-first"><strong>Authors\' contributions</strong></p><p id="__p44" class="p p-last">YL carried out the cell and animal manipulation, the CTL cytolysis assay. ZR carried out the immunoassays. LW participated in the design of the study and performed the statistical analysis. BN and YW conceived of the study, and participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.</p></p></div></div><div id="idm140138195365440aff-info" class="tsec sec"><h2 class="head no_bottom_margin" id="idm140138195365440aff-infotitle">Contributor Information</h2><p><span class="fm-affl">Yanbo Lv, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="nc.moc.anis@lyob" class="oemail">nc.moc.anis@lyob</a></span>.</p><p><span class="fm-affl">Zhihua Ruan, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.liamtoh@6002ihz" class="oemail">moc.liamtoh@6002ihz</a></span>.</p><p><span class="fm-affl">Li Wang, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ten.361@il8002_gnaW" class="oemail">ten.361@il8002_gnaW</a></span>.</p><p><span class="fm-affl">Bing Ni, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@ixgnibin" class="oemail">moc.oohay@ixgnibin</a></span>.</p><p><span class="fm-affl">Yuzhang Wu, </span><span class="fm-affl"><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="moc.oohay@wgnahzuy" class="oemail">moc.oohay@wgnahzuy</a></span>.</p></div><div id="Bib1" class="tsec sec"><h2 class="head no_bottom_margin" id="Bib1title">References</h2><div class="ref-list-sec sec" id="reference-list"><div class="ref-cit-blk half_rhythm" id="CR1">1. <span class="element-citation">Drosten C, Gunther S, Preiser W, Werf S van der, Brodt HR, Becker S, Rabenau H, Panning M, Kolesnikova L, Fouchier RA, et al.  Identification of a novel coronavirus in patients with severe acute respiratory syndrome. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1967\xe2\x80\x9376. doi: 10.1056/NEJMoa030747.</span> [<a href="/pubmed/12690091" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa030747" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=Identification+of+a+novel+coronavirus+in+patients+with+severe+acute+respiratory+syndrome&amp;author=C+Drosten&amp;author=S+Gunther&amp;author=W+Preiser&amp;author=S+van+der+Werf&amp;author=HR+Brodt&amp;volume=348&amp;publication_year=2003&amp;pages=1967-76&amp;pmid=12690091&amp;doi=10.1056/NEJMoa030747&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR2">2. <span class="element-citation">Ksiazek TG, Erdman D, Goldsmith CS, Zaki SR, Peret T, Emery S, Tong S, Urbani C, Comer JA, Lim W, et al.  A novel coronavirus associated with severe acute respiratory syndrome. <span><span class="ref-journal">N Engl J Med. </span>2003;<span class="ref-vol">348</span>:1953\xe2\x80\x9366. doi: 10.1056/NEJMoa030781.</span> [<a href="/pubmed/12690092" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1056%2FNEJMoa030781" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=N+Engl+J+Med&amp;title=A+novel+coronavirus+associated+with+severe+acute+respiratory+syndrome&amp;author=TG+Ksiazek&amp;author=D+Erdman&amp;author=CS+Goldsmith&amp;author=SR+Zaki&amp;author=T+Peret&amp;volume=348&amp;publication_year=2003&amp;pages=1953-66&amp;pmid=12690092&amp;doi=10.1056/NEJMoa030781&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR3">3. <span class="element-citation">Peiris JS, Lai ST, Poon LL, Guan Y, Yam LY, Lim W, Nicholls J, Yee WK, Yan WW, Cheung MT, et al.  Coronavirus as a possible cause of severe acute respiratory syndrome. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">361</span>:1319\xe2\x80\x9325. doi: 10.1016/S0140-6736(03)13077-2.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112372/">PMC free article</a>]</span> [<a href="/pubmed/12711465" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(03)13077-2" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Coronavirus+as+a+possible+cause+of+severe+acute+respiratory+syndrome&amp;author=JS+Peiris&amp;author=ST+Lai&amp;author=LL+Poon&amp;author=Y+Guan&amp;author=LY+Yam&amp;volume=361&amp;publication_year=2003&amp;pages=1319-25&amp;pmid=12711465&amp;doi=10.1016/S0140-6736(03)13077-2&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR4">4. <span class="element-citation">Guan Y, Zheng BJ, He YQ, Liu XL, Zhuang ZX, Cheung CL, Luo SW, Li PH, Zhang LJ, Guan YJ, et al.  Isolation and characterization of viruses related to the SARS coronavirus from animals in southern China. <span><span class="ref-journal">Science. </span>2003;<span class="ref-vol">302</span>:276\xe2\x80\x938. doi: 10.1126/science.1087139.</span> [<a href="/pubmed/12958366" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.1087139" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Isolation+and+characterization+of+viruses+related+to+the+SARS+coronavirus+from+animals+in+southern+China&amp;author=Y+Guan&amp;author=BJ+Zheng&amp;author=YQ+He&amp;author=XL+Liu&amp;author=ZX+Zhuang&amp;volume=302&amp;publication_year=2003&amp;pages=276-8&amp;pmid=12958366&amp;doi=10.1126/science.1087139&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR5">5. <span class="element-citation">Skowronski DM, Astell C, Brunham RC, Low DE, Petric M, Roper RL, Talbot PJ, Tam T, Babiuk L. Severe acute respiratory syndrome (SARS): a year in review. <span><span class="ref-journal">Annu Rev Med. </span>2005;<span class="ref-vol">56</span>:357\xe2\x80\x9381. doi: 10.1146/annurev.med.56.091103.134135.</span> [<a href="/pubmed/15660517" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1146%2Fannurev.med.56.091103.134135" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Annu+Rev+Med&amp;title=Severe+acute+respiratory+syndrome+(SARS):+a+year+in+review&amp;author=DM+Skowronski&amp;author=C+Astell&amp;author=RC+Brunham&amp;author=DE+Low&amp;author=M+Petric&amp;volume=56&amp;publication_year=2005&amp;pages=357-81&amp;pmid=15660517&amp;doi=10.1146/annurev.med.56.091103.134135&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR6">6. <span class="element-citation">Normile D. Infectious diseases. Mounting lab accidents raise SARS fears. <span><span class="ref-journal">Science. </span>2004;<span class="ref-vol">304</span>:659\xe2\x80\x9361. doi: 10.1126/science.304.5671.659.</span> [<a href="/pubmed/15118129" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1126%2Fscience.304.5671.659" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Science&amp;title=Infectious+diseases.+Mounting+lab+accidents+raise+SARS+fears&amp;author=D+Normile&amp;volume=304&amp;publication_year=2004&amp;pages=659-61&amp;pmid=15118129&amp;doi=10.1126/science.304.5671.659&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR7">7. <span class="element-citation">Orellana C. Laboratory-acquired SARS raises worries on biosafety. <span><span class="ref-journal">Lancet Infect Dis. </span>2004;<span class="ref-vol">4</span>:64. doi: 10.1016/S1473-3099(04)00911-9.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7128204/">PMC free article</a>]</span> [<a href="/pubmed/14959754" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS1473-3099(04)00911-9" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Infect+Dis&amp;title=Laboratory-acquired+SARS+raises+worries+on+biosafety&amp;author=C+Orellana&amp;volume=4&amp;publication_year=2004&amp;pages=64&amp;pmid=14959754&amp;doi=10.1016/S1473-3099(04)00911-9&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR8">8. <span class="element-citation">Paterson R. SARS returns to China. <span><span class="ref-journal">Lancet Infect Dis. </span>2004;<span class="ref-vol">4</span>:64. doi: 10.1016/S1473-3099(04)00910-7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7129947/">PMC free article</a>]</span> [<a href="/pubmed/14959753" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS1473-3099(04)00910-7" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet+Infect+Dis&amp;title=SARS+returns+to+China&amp;author=R+Paterson&amp;volume=4&amp;publication_year=2004&amp;pages=64&amp;pmid=14959753&amp;doi=10.1016/S1473-3099(04)00910-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR9">9. <span class="mixed-citation">Emergence of a Novel Swine-Origin Influenza A (H1N1) Virus in Humans. N Engl J Med. 2009 [<a href="/pubmed/19423869" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>]</span></div><div class="ref-cit-blk half_rhythm" id="CR10">10. <span class="element-citation">Xu X, Gao X. Immunological responses against SARS-coronavirus infection in humans. <span><span class="ref-journal">Cell Mol Immunol. </span>2004;<span class="ref-vol">1</span>:119\xe2\x80\x9322.</span> [<a href="/pubmed/16212898" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cell+Mol+Immunol&amp;title=Immunological+responses+against+SARS-coronavirus+infection+in+humans&amp;author=X+Xu&amp;author=X+Gao&amp;volume=1&amp;publication_year=2004&amp;pages=119-22&amp;pmid=16212898&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR11">11. <span class="element-citation">Zhong X, Yang H, Guo ZF, Sin WY, Chen W, Xu J, Fu L, Wu J, Mak CK, Cheng CS, et al.  B-cell responses in patients who have recovered from severe acute respiratory syndrome target a dominant site in the S2 domain of the surface spike glycoprotein. <span><span class="ref-journal">J Virol. </span>2005;<span class="ref-vol">79</span>:3401\xe2\x80\x938. doi: 10.1128/JVI.79.6.3401-3408.2005.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1075701/">PMC free article</a>]</span> [<a href="/pubmed/15731234" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1128%2FJVI.79.6.3401-3408.2005" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Virol&amp;title=B-cell+responses+in+patients+who+have+recovered+from+severe+acute+respiratory+syndrome+target+a+dominant+site+in+the+S2+domain+of+the+surface+spike+glycoprotein&amp;author=X+Zhong&amp;author=H+Yang&amp;author=ZF+Guo&amp;author=WY+Sin&amp;author=W+Chen&amp;volume=79&amp;publication_year=2005&amp;pages=3401-8&amp;pmid=15731234&amp;doi=10.1128/JVI.79.6.3401-3408.2005&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR12">12. <span class="element-citation">Li T, Xie J, He Y, Fan H, Baril L, Qiu Z, Han Y, Xu W, Zhang W, You H, et al.  Long-term persistence of robust antibody and cytotoxic T cell responses in recovered patients infected with SARS coronavirus. <span><span class="ref-journal">PLoS ONE. </span>2006;<span class="ref-vol">1</span>:e24. doi: 10.1371/journal.pone.0000024.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1762349/">PMC free article</a>]</span> [<a href="/pubmed/17183651" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1371%2Fjournal.pone.0000024" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=PLoS+ONE&amp;title=Long-term+persistence+of+robust+antibody+and+cytotoxic+T+cell+responses+in+recovered+patients+infected+with+SARS+coronavirus&amp;author=T+Li&amp;author=J+Xie&amp;author=Y+He&amp;author=H+Fan&amp;author=L+Baril&amp;volume=1&amp;publication_year=2006&amp;pages=e24&amp;pmid=17183651&amp;doi=10.1371/journal.pone.0000024&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR13">13. <span class="element-citation">Dutta NK, Mazumdar K, Lee BH, Baek MW, Kim DJ, Na YR, Park SH, Lee HK, Kariwa H, Mai le Q, et al.  Search for potential target site of nucleocapsid gene for the design of an epitope-based SARS DNA vaccine. <span><span class="ref-journal">Immunol Lett. </span>2008;<span class="ref-vol">118</span>:65\xe2\x80\x9371. doi: 10.1016/j.imlet.2008.03.003.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112843/">PMC free article</a>]</span> [<a href="/pubmed/18440652" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.imlet.2008.03.003" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Lett&amp;title=Search+for+potential+target+site+of+nucleocapsid+gene+for+the+design+of+an+epitope-based+SARS+DNA+vaccine&amp;author=NK+Dutta&amp;author=K+Mazumdar&amp;author=BH+Lee&amp;author=MW+Baek&amp;author=DJ+Kim&amp;volume=118&amp;publication_year=2008&amp;pages=65-71&amp;pmid=18440652&amp;doi=10.1016/j.imlet.2008.03.003&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR14">14. <span class="element-citation">Jin H, Xiao C, Chen Z, Kang Y, Ma Y, Zhu K, Xie Q, Tu Y, Yu Y, Wang B. Induction of Th1 type response by DNA vaccinations with N, M, and E genes against SARS-CoV in mice. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2005;<span class="ref-vol">328</span>:979\xe2\x80\x9386. doi: 10.1016/j.bbrc.2005.01.048.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7092846/">PMC free article</a>]</span> [<a href="/pubmed/15707974" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.bbrc.2005.01.048" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=Induction+of+Th1+type+response+by+DNA+vaccinations+with+N,+M,+and+E+genes+against+SARS-CoV+in+mice&amp;author=H+Jin&amp;author=C+Xiao&amp;author=Z+Chen&amp;author=Y+Kang&amp;author=Y+Ma&amp;volume=328&amp;publication_year=2005&amp;pages=979-86&amp;pmid=15707974&amp;doi=10.1016/j.bbrc.2005.01.048&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR15">15. <span class="element-citation">See RH, Petric M, Lawrence DJ, Mok CP, Rowe T, Zitzow LA, Karunakaran KP, Voss TG, Brunham RC, Gauldie J, et al.  Severe acute respiratory syndrome vaccine efficacy in ferrets: whole killed virus and adenovirus-vectored vaccines. <span><span class="ref-journal">J Gen Virol. </span>2008;<span class="ref-vol">89</span>:2136\xe2\x80\x9346. doi: 10.1099/vir.0.2008/001891-0.</span> [<a href="/pubmed/18753223" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1099%2Fvir.0.2008%2F001891-0" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Gen+Virol&amp;title=Severe+acute+respiratory+syndrome+vaccine+efficacy+in+ferrets:+whole+killed+virus+and+adenovirus-vectored+vaccines&amp;author=RH+See&amp;author=M+Petric&amp;author=DJ+Lawrence&amp;author=CP+Mok&amp;author=T+Rowe&amp;volume=89&amp;publication_year=2008&amp;pages=2136-46&amp;pmid=18753223&amp;doi=10.1099/vir.0.2008/001891-0&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR16">16. <span class="element-citation">Buchholz UJ, Bukreyev A, Yang L, Lamirande EW, Murphy BR, Subbarao K, Collins PL. Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. <span><span class="ref-journal">Proc Natl Acad Sci USA. </span>2004;<span class="ref-vol">101</span>:9804\xe2\x80\x939. doi: 10.1073/pnas.0403492101.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC470755/">PMC free article</a>]</span> [<a href="/pubmed/15210961" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1073%2Fpnas.0403492101" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Proc+Natl+Acad+Sci+USA&amp;title=Contributions+of+the+structural+proteins+of+severe+acute+respiratory+syndrome+coronavirus+to+protective+immunity&amp;author=UJ+Buchholz&amp;author=A+Bukreyev&amp;author=L+Yang&amp;author=EW+Lamirande&amp;author=BR+Murphy&amp;volume=101&amp;publication_year=2004&amp;pages=9804-9&amp;pmid=15210961&amp;doi=10.1073/pnas.0403492101&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR17">17. <span class="element-citation">Zakhartchouk AN, Sharon C, Satkunarajah M, Auperin T, Viswanathan S, Mutwiri G, Petric M, See RH, Brunham RC, Finlay BB, et al.  Immunogenicity of a receptor-binding domain of SARS coronavirus spike protein in mice: implications for a subunit vaccine. <span><span class="ref-journal">Vaccine. </span>2007;<span class="ref-vol">25</span>:136\xe2\x80\x9343. doi: 10.1016/j.vaccine.2006.06.084.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7115608/">PMC free article</a>]</span> [<a href="/pubmed/16919855" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.vaccine.2006.06.084" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Immunogenicity+of+a+receptor-binding+domain+of+SARS+coronavirus+spike+protein+in+mice:+implications+for+a+subunit+vaccine&amp;author=AN+Zakhartchouk&amp;author=C+Sharon&amp;author=M+Satkunarajah&amp;author=T+Auperin&amp;author=S+Viswanathan&amp;volume=25&amp;publication_year=2007&amp;pages=136-43&amp;pmid=16919855&amp;doi=10.1016/j.vaccine.2006.06.084&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR18">18. <span class="element-citation">Zhi Y, Kobinger GP, Jordan H, Suchma K, Weiss SR, Shen H, Schumer G, Gao G, Boyer JL, Crystal RG, et al.  Identification of murine CD8 T cell epitopes in codon-optimized SARS-associated coronavirus spike protein. <span><span class="ref-journal">Virology. </span>2005;<span class="ref-vol">335</span>:34\xe2\x80\x9345. doi: 10.1016/j.virol.2005.01.050.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7111773/">PMC free article</a>]</span> [<a href="/pubmed/15823604" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.virol.2005.01.050" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Virology&amp;title=Identification+of+murine+CD8+T+cell+epitopes+in+codon-optimized+SARS-associated+coronavirus+spike+protein&amp;author=Y+Zhi&amp;author=GP+Kobinger&amp;author=H+Jordan&amp;author=K+Suchma&amp;author=SR+Weiss&amp;volume=335&amp;publication_year=2005&amp;pages=34-45&amp;pmid=15823604&amp;doi=10.1016/j.virol.2005.01.050&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR19">19. <span class="element-citation">Du L, He Y, Zhou Y, Liu S, Zheng BJ, Jiang S. The spike protein of SARS-CoV--a target for vaccine and therapeutic development. <span><span class="ref-journal">Nat Rev Microbiol. </span>2009;<span class="ref-vol">7</span>:226\xe2\x80\x9336. doi: 10.1038/nrmicro2090.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2750777/">PMC free article</a>]</span> [<a href="/pubmed/19198616" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1038%2Fnrmicro2090" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Nat+Rev+Microbiol&amp;title=The+spike+protein+of+SARS-CoV--a+target+for+vaccine+and+therapeutic+development&amp;author=L+Du&amp;author=Y+He&amp;author=Y+Zhou&amp;author=S+Liu&amp;author=BJ+Zheng&amp;volume=7&amp;publication_year=2009&amp;pages=226-36&amp;pmid=19198616&amp;doi=10.1038/nrmicro2090&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR20">20. <span class="element-citation">Zhang CY, Wei JF, He SH. Adaptive evolution of the spike gene of SARS coronavirus: changes in positively selected sites in different epidemic groups. <span><span class="ref-journal">BMC Microbiol. </span>2006;<span class="ref-vol">6</span>:88. doi: 10.1186/1471-2180-6-88.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1609170/">PMC free article</a>]</span> [<a href="/pubmed/17020602" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1186%2F1471-2180-6-88" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=BMC+Microbiol&amp;title=Adaptive+evolution+of+the+spike+gene+of+SARS+coronavirus:+changes+in+positively+selected+sites+in+different+epidemic+groups&amp;author=CY+Zhang&amp;author=JF+Wei&amp;author=SH+He&amp;volume=6&amp;publication_year=2006&amp;pages=88&amp;pmid=17020602&amp;doi=10.1186/1471-2180-6-88&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR21">21. <span class="element-citation">Tang X, Yin C, Zhang F, Fu Y, Chen W, Chen Y, Wang J, Jia W, Xu A. Measurement of subgroups of peripheral blood T lymphocytes in patients with severe acute respiratory syndrome and its clinical significance. <span><span class="ref-journal">Chin Med J (Engl) </span>2003;<span class="ref-vol">116</span>:827\xe2\x80\x9330.</span> [<a href="/pubmed/12877788" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Chin+Med+J+(Engl)&amp;title=Measurement+of+subgroups+of+peripheral+blood+T+lymphocytes+in+patients+with+severe+acute+respiratory+syndrome+and+its+clinical+significance&amp;author=X+Tang&amp;author=C+Yin&amp;author=F+Zhang&amp;author=Y+Fu&amp;author=W+Chen&amp;volume=116&amp;publication_year=2003&amp;pages=827-30&amp;pmid=12877788&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR22">22. <span class="element-citation">Sidney J, Grey HM, Kubo RT, Sette A. Practical, biochemical and evolutionary implications of the discovery of HLA class I supermotifs. <span><span class="ref-journal">Immunol Today. </span>1996;<span class="ref-vol">17</span>:261\xe2\x80\x936. doi: 10.1016/0167-5699(96)80542-1.</span> [<a href="/pubmed/8962628" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2F0167-5699(96)80542-1" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunol+Today&amp;title=Practical,+biochemical+and+evolutionary+implications+of+the+discovery+of+HLA+class+I+supermotifs&amp;author=J+Sidney&amp;author=HM+Grey&amp;author=RT+Kubo&amp;author=A+Sette&amp;volume=17&amp;publication_year=1996&amp;pages=261-6&amp;pmid=8962628&amp;doi=10.1016/0167-5699(96)80542-1&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR23">23. <span class="element-citation">Chen H, Hou J, Jiang X, Ma S, Meng M, Wang B, Zhang M, Zhang M, Tang X, Zhang F, et al.  Response of memory CD8+ T cells to severe acute respiratory syndrome (SARS) coronavirus in recovered SARS patients and healthy individuals. <span><span class="ref-journal">J Immunol. </span>2005;<span class="ref-vol">175</span>:591\xe2\x80\x938. doi: 10.4049/jimmunol.175.1.591.</span> [<a href="/pubmed/15972696" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.4049%2Fjimmunol.175.1.591" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Response+of+memory+CD8++T+cells+to+severe+acute+respiratory+syndrome+(SARS)+coronavirus+in+recovered+SARS+patients+and+healthy+individuals&amp;author=H+Chen&amp;author=J+Hou&amp;author=X+Jiang&amp;author=S+Ma&amp;author=M+Meng&amp;volume=175&amp;publication_year=2005&amp;pages=591-8&amp;pmid=15972696&amp;doi=10.4049/jimmunol.175.1.591&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR24">24. <span class="element-citation">Tsao YP, Lin JY, Jan JT, Leng CH, Chu CC, Yang YC, Chen SL. HLA-A*0201 T-cell epitopes in severe acute respiratory syndrome (SARS) coronavirus nucleocapsid and spike proteins. <span><span class="ref-journal">Biochem Biophys Res Commun. </span>2006;<span class="ref-vol">344</span>:63\xe2\x80\x9371. doi: 10.1016/j.bbrc.2006.03.152.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7092919/">PMC free article</a>]</span> [<a href="/pubmed/16630549" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.bbrc.2006.03.152" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Biochem+Biophys+Res+Commun&amp;title=HLA-A*0201+T-cell+epitopes+in+severe+acute+respiratory+syndrome+(SARS)+coronavirus+nucleocapsid+and+spike+proteins&amp;author=YP+Tsao&amp;author=JY+Lin&amp;author=JT+Jan&amp;author=CH+Leng&amp;author=CC+Chu&amp;volume=344&amp;publication_year=2006&amp;pages=63-71&amp;pmid=16630549&amp;doi=10.1016/j.bbrc.2006.03.152&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR25">25. <span class="element-citation">Wang YD, Chen WF. Detecting specific cytotoxic T lymphocytes against SARS-coronavirus with DimerX HLA-A2:Ig fusion protein. <span><span class="ref-journal">Clin Immunol. </span>2004;<span class="ref-vol">113</span>:151\xe2\x80\x934. doi: 10.1016/j.clim.2004.07.004.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7106176/">PMC free article</a>]</span> [<a href="/pubmed/15451471" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.clim.2004.07.004" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Clin+Immunol&amp;title=Detecting+specific+cytotoxic+T+lymphocytes+against+SARS-coronavirus+with+DimerX+HLA-A2:Ig+fusion+protein&amp;author=YD+Wang&amp;author=WF+Chen&amp;volume=113&amp;publication_year=2004&amp;pages=151-4&amp;pmid=15451471&amp;doi=10.1016/j.clim.2004.07.004&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR26">26. <span class="element-citation">Zhou M, Xu D, Li X, Li H, Shan M, Tang J, Wang M, Wang FS, Zhu X, Tao H, et al.  Screening and identification of severe acute respiratory syndrome-associated coronavirus-specific CTL epitopes. <span><span class="ref-journal">J Immunol. </span>2006;<span class="ref-vol">177</span>:2138\xe2\x80\x9345. doi: 10.4049/jimmunol.177.4.2138.</span> [<a href="/pubmed/16887973" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.4049%2Fjimmunol.177.4.2138" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Screening+and+identification+of+severe+acute+respiratory+syndrome-associated+coronavirus-specific+CTL+epitopes&amp;author=M+Zhou&amp;author=D+Xu&amp;author=X+Li&amp;author=H+Li&amp;author=M+Shan&amp;volume=177&amp;publication_year=2006&amp;pages=2138-45&amp;pmid=16887973&amp;doi=10.4049/jimmunol.177.4.2138&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR27">27. <span class="element-citation">Huang J, Cao Y, Du J, Bu X, Ma R, Wu C. Priming with SARS CoV S DNA and boosting with SARS CoV S epitopes specific for CD4+ and CD8+ T cells promote cellular immune responses. <span><span class="ref-journal">Vaccine. </span>2007;<span class="ref-vol">25</span>:6981\xe2\x80\x9391. doi: 10.1016/j.vaccine.2007.06.047.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7115420/">PMC free article</a>]</span> [<a href="/pubmed/17709158" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2Fj.vaccine.2007.06.047" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Vaccine&amp;title=Priming+with+SARS+CoV+S+DNA+and+boosting+with+SARS+CoV+S+epitopes+specific+for+CD4++and+CD8++T+cells+promote+cellular+immune+responses&amp;author=J+Huang&amp;author=Y+Cao&amp;author=J+Du&amp;author=X+Bu&amp;author=R+Ma&amp;volume=25&amp;publication_year=2007&amp;pages=6981-91&amp;pmid=17709158&amp;doi=10.1016/j.vaccine.2007.06.047&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR28">28. <span class="element-citation">Passoni L, Scardino A, Bertazzoli C, Gallo B, Coluccia AM, Lemonnier FA, Kosmatopoulos K, Gambacorti-Passerini C. ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes. <span><span class="ref-journal">Blood. </span>2002;<span class="ref-vol">99</span>:2100\xe2\x80\x936. doi: 10.1182/blood.V99.6.2100.</span> [<a href="/pubmed/11877285" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1182%2Fblood.V99.6.2100" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Blood&amp;title=ALK+as+a+novel+lymphoma-associated+tumor+antigen:+identification+of+2+HLA-A2.1-restricted+CD8++T-cell+epitopes&amp;author=L+Passoni&amp;author=A+Scardino&amp;author=C+Bertazzoli&amp;author=B+Gallo&amp;author=AM+Coluccia&amp;volume=99&amp;publication_year=2002&amp;pages=2100-6&amp;pmid=11877285&amp;doi=10.1182/blood.V99.6.2100&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR29">29. <span class="element-citation">Salter RD, Cresswell P. Impaired assembly and transport of HLA-A and -B antigens in a mutant TxB cell hybrid. <span><span class="ref-journal">Embo J. </span>1986;<span class="ref-vol">5</span>:943\xe2\x80\x939.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC1166886/">PMC free article</a>]</span> [<a href="/pubmed/3522223" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Embo+J&amp;title=Impaired+assembly+and+transport+of+HLA-A+and+-B+antigens+in+a+mutant+TxB+cell+hybrid&amp;author=RD+Salter&amp;author=P+Cresswell&amp;volume=5&amp;publication_year=1986&amp;pages=943-9&amp;pmid=3522223&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR30">30. <span class="element-citation">Nicholls JM, Poon LL, Lee KC, Ng WF, Lai ST, Leung CY, Chu CM, Hui PK, Mak KL, Lim W, et al.  Lung pathology of fatal severe acute respiratory syndrome. <span><span class="ref-journal">Lancet. </span>2003;<span class="ref-vol">361</span>:1773\xe2\x80\x938. doi: 10.1016/S0140-6736(03)13413-7.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC7112492/">PMC free article</a>]</span> [<a href="/pubmed/12781536" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0140-6736(03)13413-7" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Lancet&amp;title=Lung+pathology+of+fatal+severe+acute+respiratory+syndrome&amp;author=JM+Nicholls&amp;author=LL+Poon&amp;author=KC+Lee&amp;author=WF+Ng&amp;author=ST+Lai&amp;volume=361&amp;publication_year=2003&amp;pages=1773-8&amp;pmid=12781536&amp;doi=10.1016/S0140-6736(03)13413-7&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR31">31. <span class="element-citation">Singh H, Raghava GP. ProPred1: prediction of promiscuous MHC Class-I binding sites. <span><span class="ref-journal">Bioinformatics. </span>2003;<span class="ref-vol">19</span>:1009\xe2\x80\x9314. doi: 10.1093/bioinformatics/btg108.</span> [<a href="/pubmed/12761064" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1093%2Fbioinformatics%2Fbtg108" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Bioinformatics&amp;title=ProPred1:+prediction+of+promiscuous+MHC+Class-I+binding+sites&amp;author=H+Singh&amp;author=GP+Raghava&amp;volume=19&amp;publication_year=2003&amp;pages=1009-14&amp;pmid=12761064&amp;doi=10.1093/bioinformatics/btg108&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR32">32. <span class="element-citation">Rammensee H, Bachmann J, Emmerich NP, Bachor OA, Stevanovic S. SYFPEITHI: database for MHC ligands and peptide motifs. <span><span class="ref-journal">Immunogenetics. </span>1999;<span class="ref-vol">50</span>:213\xe2\x80\x939. doi: 10.1007/s002510050595.</span> [<a href="/pubmed/10602881" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1007%2Fs002510050595" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Immunogenetics&amp;title=SYFPEITHI:+database+for+MHC+ligands+and+peptide+motifs&amp;author=H+Rammensee&amp;author=J+Bachmann&amp;author=NP+Emmerich&amp;author=OA+Bachor&amp;author=S+Stevanovic&amp;volume=50&amp;publication_year=1999&amp;pages=213-9&amp;pmid=10602881&amp;doi=10.1007/s002510050595&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR33">33. <span class="element-citation">Irwin MJ, Heath WR, Sherman LA. Species-restricted interactions between CD8 and the alpha 3 domain of class I influence the magnitude of the xenogeneic response. <span><span class="ref-journal">J Exp Med. </span>1989;<span class="ref-vol">170</span>:1091\xe2\x80\x93101. doi: 10.1084/jem.170.4.1091.</span> <span class="nowrap">[<a class="int-reflink" href="/pmc/articles/PMC2189481/">PMC free article</a>]</span> [<a href="/pubmed/2477484" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1084%2Fjem.170.4.1091" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Exp+Med&amp;title=Species-restricted+interactions+between+CD8+and+the+alpha+3+domain+of+class+I+influence+the+magnitude+of+the+xenogeneic+response&amp;author=MJ+Irwin&amp;author=WR+Heath&amp;author=LA+Sherman&amp;volume=170&amp;publication_year=1989&amp;pages=1091-101&amp;pmid=2477484&amp;doi=10.1084/jem.170.4.1091&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR34">34. <span class="element-citation">Cao X, Zhang W, He L, Xie Z, Ma S, Tao Q, Yu Y, Hamada H, Wang J. Lymphotactin gene-modified bone marrow dendritic cells act as more potent adjuvants for peptide delivery to induce specific antitumor immunity. <span><span class="ref-journal">J Immunol. </span>1998;<span class="ref-vol">161</span>:6238\xe2\x80\x9344.</span> [<a href="/pubmed/9834111" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol&amp;title=Lymphotactin+gene-modified+bone+marrow+dendritic+cells+act+as+more+potent+adjuvants+for+peptide+delivery+to+induce+specific+antitumor+immunity&amp;author=X+Cao&amp;author=W+Zhang&amp;author=L+He&amp;author=Z+Xie&amp;author=S+Ma&amp;volume=161&amp;publication_year=1998&amp;pages=6238-44&amp;pmid=9834111&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR35">35. <span class="element-citation">Talmor M, Mirza A, Turley S, Mellman I, Hoffman LA, Steinman RM. Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures. <span><span class="ref-journal">Eur J Immunol. </span>1998;<span class="ref-vol">28</span>:811\xe2\x80\x937. doi: 10.1002/(SICI)1521-4141(199803)28:03&#x0003c;811::AID-IMMU811&#x0003e;3.0.CO;2-S.</span> [<a href="/pubmed/9541575" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1002%2F(SICI)1521-4141(199803)28%3A03%3C811%3A%3AAID-IMMU811%3E3.0.CO%3B2-S" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Eur+J+Immunol&amp;title=Generation+or+large+numbers+of+immature+and+mature+dendritic+cells+from+rat+bone+marrow+cultures&amp;author=M+Talmor&amp;author=A+Mirza&amp;author=S+Turley&amp;author=I+Mellman&amp;author=LA+Hoffman&amp;volume=28&amp;publication_year=1998&amp;pages=811-7&amp;pmid=9541575&amp;doi=10.1002/(SICI)1521-4141(199803)28:03&#x0003c;811::AID-IMMU811&#x0003e;3.0.CO;2-S&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR36">36. <span class="element-citation">Xiang R, Lode HN, Dreier T, Gillies SD, Reisfeld RA. Induction of persistent tumor-protective immunity in mice cured of established colon carcinoma metastases. <span><span class="ref-journal">Cancer Res. </span>1998;<span class="ref-vol">58</span>:3918\xe2\x80\x9325.</span> [<a href="/pubmed/9731503" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=Cancer+Res&amp;title=Induction+of+persistent+tumor-protective+immunity+in+mice+cured+of+established+colon+carcinoma+metastases&amp;author=R+Xiang&amp;author=HN+Lode&amp;author=T+Dreier&amp;author=SD+Gillies&amp;author=RA+Reisfeld&amp;volume=58&amp;publication_year=1998&amp;pages=3918-25&amp;pmid=9731503&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div><div class="ref-cit-blk half_rhythm" id="CR37">37. <span class="element-citation">McCutcheon M, Wehner N, Wensky A, Kushner M, Doan S, Hsiao L, Calabresi P, Ha T, Tran TV, Tate KM, et al.  A sensitive ELISPOT assay to detect low-frequency human T lymphocytes. <span><span class="ref-journal">J Immunol Methods. </span>1997;<span class="ref-vol">210</span>:149\xe2\x80\x9366. doi: 10.1016/S0022-1759(97)00182-8.</span> [<a href="/pubmed/9520298" target="pmc_ext" ref="reftype=pubmed&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Entrez%7CPubMed%7CRecord">PubMed</a>] [<a href="//dx.doi.org/10.1016%2FS0022-1759(97)00182-8" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CCrosslink%7CDOI">CrossRef</a>] <span class="nowrap">[<a href="https://scholar.google.com/scholar_lookup?journal=J+Immunol+Methods&amp;title=A+sensitive+ELISPOT+assay+to+detect+low-frequency+human+T+lymphocytes&amp;author=M+McCutcheon&amp;author=N+Wehner&amp;author=A+Wensky&amp;author=M+Kushner&amp;author=S+Doan&amp;volume=210&amp;publication_year=1997&amp;pages=149-66&amp;pmid=9520298&amp;doi=10.1016/S0022-1759(97)00182-8&amp;" target="pmc_ext" ref="reftype=other&amp;article-id=2792222&amp;issue-id=354737&amp;journal-id=3814&amp;FROM=Article%7CCitationRef&amp;TO=Content%20Provider%7CLink%7CGoogle%20Scholar">Google Scholar</a>]</span></span></div></div></div></div><!--post-content--></div>\n            \n            \n        \n            \n        </div>\n        <!-- Book content -->\n    </div>\n    \n    <div id="rightcolumn" class="four_col col last">\n        <!-- Custom content above discovery portlets -->\n        <div class="col6">\n            \n        </div>\n        \n        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><div class="format-menu"><h2>Formats:</h2><ul><li class="selected">Article</li> | <li><a href="/pmc/articles/PMC2792222/?report=reader">PubReader</a></li> | <li class="epub-link"><a href="/pmc/articles/PMC2792222/epub/">ePub (beta)</a></li> | <li><a href="/pmc/articles/PMC2792222/pdf/12865_2009_Article_281.pdf">PDF (1.1M)</a></li> | <li><a href="#" data-citationid="PMC2792222" class="citationexporter ctxp">Citation</a></li></ul></div></div><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="share-buttons"><h2>Share</h2><ul><li class="facebook"><a href="https://www.facebook.com/sharer/sharer.php?u=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2792222%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047626" alt="Share on Facebook" />\n                             Facebook\n                        </a></li><li class="twitter"><a href="https://twitter.com/intent/tweet?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2792222%2F&amp;text=Identification%20of%20a%20novel%20conserved%20HLA-A*0201-restricted%20epitope%20from%20the%20spike%20protein%20of%20SARS-CoV"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047627" alt="Share on Twitter" />\n                             Twitter\n                        </a></li><li class="gplus"><a href="https://plus.google.com/share?url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2792222%2F"><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/img/4047628" alt="Share on Google Plus" />\n                             Google+\n                        </a></li></ul></div>\n        \n        <div id="ajax-portlets" data-pmid="19958537" data-aiid="7090438" data-aid="2792222" data-iid="354737" data-domainid="3814" data-domain="phenaturepg" data-accid="PMC2792222" data-md5="49a113afbb3d64bad72bf1e831b24e50"></div>\n                \n        <!-- Custom content below discovery portlets -->\n        <div class="col7">\n            \n        </div>\n    </div>\n</div>\n\n<!-- Custom content after all -->\n<div class="col8">\n    \n</div>\n<div class="col9">\n    \n</div>\n\n<script src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>\n<script>\n    (function($){\n        $(\'.skiplink\').each(function(i, item){\n            var href = $($(item).attr(\'href\'));\n            href.attr(\'tabindex\', \'-1\').addClass(\'skiptarget\'); // ensure the target can receive focus\n            $(item).on(\'click\', function(event){\n                event.preventDefault();\n                $.scrollTo(href, 0, {\n                    onAfter: function(){\n                        href.focus();\n                    }\n                });\n            });\n        });\n    })(jQuery);\n</script>\n\n\n\n<div id="body-link-poppers"></div>\n                        </div>\n                        <div class="bottom">\n                            \n                            <div id="NCBIFooter_dynamic">\n    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>\n    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2020-04-17T20:28:46-04:00&amp;Snapshot=%2Fprojects%2FPMC%2FPMCViewer@4.46&amp;Host=ptpmc102&amp;ncbi_phid=8A1B7671E9A3857100000000066D066C&amp;ncbi_session=8A1B7671E9A49BE1_1645SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fpmc%2Farticles%2FPMC2792222%2F&amp;Db=pmc&amp;folderID=132&amp;Ncbi_App=pmc&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>\n    \n</div>\n\n                            <div class="footer" id="footer">\n    \n    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>\n    <div id="external-disclaimer" class="offscreen_noflow">\n        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.\n    </div>    \n    <div id="ncbifooter" class="contact_info">      \n        <div id="footer-contents-right">\n            <div id="nlm_thumb_logo">\n                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>\n            </div>\n            <div id="nih_thumb_logo">\n                <a href="https://www.nih.gov" title="NIH">NIH</a>\n            </div>\n            <div id="hhs_thumb_logo">\n                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>\n            </div>\n            <div id="usagov_thumb_logo">\n                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>\n            </div>         \n        </div>\n        \n        <div id="footer-contents-left">\n            <p class="address vcard">\n                <span class="url">\n                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for\n                        Biotechnology Information</a>,\n                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>\n                <span class="adr">\n                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>\n                    <span class="region">MD</span>, <span class="postal-code">20894</span>\n                    <span class="country-name">USA</span>\n                </span>\n            </p>\n            \n            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>\n        </div>\n    </div>\n    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    \n    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>\n</div>\n                        </div>\n                    </div>\n                    <!--/.page-->\n                </div>\n                <!--/.wrap-->\n            </div><!-- /.twelve_col -->\n        </div>\n        <!-- /.grid -->\n\n        <span class="PAFAppResources"></span>\n        \n        <!-- BESelector tab -->\n        \n        \n        \n        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=pmc&amp;ncbi_pdid=article&amp;ncbi_acc=&amp;ncbi_domain=phenaturepg&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/articles/PMC2792222/&amp;ncbi_app=pmc" /></noscript>\n        \n        \n        <!-- usually for JS scripts at page bottom -->\n        <!--<component id="PageFixtures" label="styles"></component>-->\n    \n\n<!-- 8A1B7671E9A49BE1_1645SID /projects/PMC/PMCViewer@4.46 ptpmc102 v4.1.r585844 Mon, May 06 2019 02:53:16 -->\n\n<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4160049/js/3879255/4121861/3818874/4168176/3821238/4117325/4087685/4072593/4076480/3921943/4105668/4065628.js" snapshot="pmc"></script></body>\n</html>'